Curriculum Vitae Ted Warren Reid, Ph.D. revised 11/27/2012
Office Address: Texas Tech University Health Sciences Center Department of Ophthalmology and Visual Sciences Lubbock, Texas 79430 Telephone (806) 743-2400
EDUCATION: B.A., Occidental College, Los Angeles 1961 M.S., University of Arizona, Tucson 1963 Ph.D., University of California, Los Angeles 1967
HONORS/AWARDS: Research to Prevent Blindness Professorship, Yale University 1973 Fellow, Silliman College, Yale University 1974-79 Visiting Fellow, Imperial Cancer Research Fund, London, England 1980 Association of Research in Vision and Ophthalmology Silver Fellow 2010 Signa Psi, Science Honor Society Golden Key National Honor Society Phi Kappa Phi Honor Society
DIRECTORSHIPS: Director of Undergraduate Studies 1975-76 Molecular Biophysics and Biochemistry Yale University
Director of Medical Research 1978-84 Ophthalmology and Visual Science Yale University School of Medicine
Director of Ophthalmic Research 1984-91 Ophthalmology Department University of California, Davis, School of Medicine
Director of Ocular Cell Biology 1991- Present Department of Ophthalmology and Visual Sciences Texas Tech University Health Sciences Center
Vice Chairman 1991- Present Department of Ophthalmology and Visual Science Texas Tech University Health Science Center
Director of Biotechnology Program 2011-Present Texas Tech University Health Sciences Center Lubbock Campus Ted W. Reid, Ph.D. 2 Rev 11-27-12 ACADEMIC APPOINTMENTS
National Institutes of Health Postdoctoral Fellow 1967-70 University of Colorado, Boulder
Assistant Professor 1970-75 Department of Ophthalmology and Visual Science, and Department of Molecular Biophysics and Biochemistry Yale University School of Medicine
Associate Professor 1975-79 Department of Biophysics and Biochemistry Yale University School of Medicine
Associate Professor 1975-79 Department of Ophthalmology and Visual Science Yale University School of Medicine
Visiting Fellow 1980 Imperial Cancer Research Fund London, England
Senior Research Scientist 1981-84 Department of Ophthalmology and Visual Science Yale University School of Medicine
Senior Research Scientist 1982-84 Division of Oncology Yale University
Visiting Fellow 1984 National Eye Institute National Institutes of Health
Professor 1984-90 Department of Ophthalmology and Visual Science University of California, Davis
Professor 1985-90 Department of Integrated Studies University of California, Davis
Professor 1985-90 Biological Sciences – Graduate Division University of California, Davis
Professor 1990- Present Department of Ophthalmology and Visual Sciences Texas Tech University Health Sciences Center Ted W. Reid, Ph.D. 3 Rev 11-27-12
Professor - Adjunct 1992- Present Department of Chemistry and Biochemistry Texas Tech University
Professor – Associate Member 1997- Present Southwest Cancer Center Texas Tech University Health Sciences Center
Professor-Associate 2003- Present Department of Microbiology and Immunology Texas Tech University Health Sciences Center
Co-Director 2011-Present Biotechnology Program Texas Tech University Health Sciences Center
BOARD MEMBERSHIPS Board Member 1986-2004 Western Eye Research Conference (ARVO)
Member of Board 1996-2003 Entrepreneurial Family Business Institute College of Business Administration Texas Tech University
Board Member (Affiliate) 1996-Present Comparative Ophthalmic Research Laboratories University of Wisconsin, Madison, WI
Guest Editorial Board Member 1998-Pesent Investigative Ophthalmology and Visual Science Bethesda, MD
Board Member 1995-Present Selenium Technologies Inc. Lubbock, TX
Board Member 2000-2011 PharmaSe Inc. Lubbock, TX
Board Member 2001-Present Eburon Organic International, Inc. Lubbock, TX
Board Member 2002-Present Center for the Advancement of Rational Solutions Lincoln, NB Ted W. Reid, Ph.D. 4 Rev 11-27-12 Board Member City of Lubbock, Board of Public Health 2009-Present
PROFESSIONAL SOCIETIES: American Chemical Society American Society for Cell Biology American Association for the Advancement of Science Association for Research in Vision and Ophthalmology International Neuropeptide Society International Society for Eye Research Golden Key National Honor Society New York Academy of Sciences Phi Kappa Phi Honor Society Protein Society Sigma Xi Society for Biomaterials Surfaces in Biomaterials Foundation
Society Offices
Member, Program planning committee – Association for Research In Vision and Ophthalmology 1989-1992
Member, Surfaces in Biomaterials Foundation Awards and Nomination Comm. 1998-1999
Chairman; South Plains Section of the American Chemical Society 1999-2000
Chairman; Ophthalmology Section of the Society for Biomaterials 2000-2001
Vice President; Sigma Xi, Texas Tech University Chapter 2002-2003 President; Sigma Xi, Texas Tech University Chapter 2010-2011 Ted W. Reid, Ph.D. 5 Rev 11-27-12 BIBLIOGRAPHY:
1. 1963 Steelink, C., Reid, T. and Tollin, G. On the nature of the free-radical moiety in lignin. J. Amer. Chem. Soc. 85:4048-4049.
2. 1963 Tollin, G., Reid, T. and Steelink, C. Structure of humic acid IV. Electron- paramagnetic resonance studies. Biochem. Biophys. Acta 66:444-447.
3. 1967 Reid, T. W. and Fahrney, D. The pepsin catalyzed hydrolysis of sulfite esters. J. Amer. Chem. Soc. 89:3941-3943.
4. 1967 Reid, T.W., Stein, T.P. and Fahrney, D. The pepsin catalyzed hydrolysis of sulfite esters. II. Resolution of alkyl phenyl sulfites. J. Amer. Chem. Soc. 89:7125-7126.
5. 1969 Lavine, D., Reid, T.W. and Wilson, I.B. The free energy of hydrolysis of the phosphoryl-enzyme intermediate in alkaline phosphatase catalyzed reactions. Biochemistry 8:2374-2380.
6. 1969 Reid, T.W., Pavlic, M., Sullivan, D.J. and Wilson, I.B. The mechanistic significance of phosphate labeling of alkaline phosphatase. Biochemistry 8:3184-3188.
7. 1970 Froede, H.C., Cowan, J., Reid, T.W. and Wilson, I.B. A rapid sampler for intermediate speed reactions. Anal. Chem. 42:1204-1210.
8. 1971 Reid, T.W. and Wilson, I.B. Conformational isomers of alkaline phosphatase in the mechanism of hydrolysis. Biochemistry 10:380-387.
9. 1971 Stein, T.P., Reid, T.W. and Fahrney, D. A useful spectrophotometric rate assay for pepsin. Anal. Biochem. 41:360-364.
10. 1971 Reid, T.W. and Wilson, I.B. E. coli alkaline phosphatase. In The Enzymes, vol. 4, ed. P.D. Boyer, pp. 373-415. New York: Academic Press.
11. 1972 Reid, T.W. and Albert, D.M. RNA-dependent DNA-polymerase activity in human tumors. Biochem. Biophys. Commun. Rep. 46:383-390.
12. 1973 Albert, D.M. and Reid, T.W. RNA-directed DNA-polymerase activity in retinoblastoma: report of its presence and possible significance. Amer. Acad. Ophth. Otol. 77:630-640.
13. 1973 Reid, T.W., Darling, T.L., Russell, P. and Albert, D.M. RNA-directed DNA- polymerase activity in Greene hamster melanoma. Yale J. Biol. & Med. 46:485-491.
14. 1974 Reid, T.W., Albert, D.M., Rabson, A.S., Russell, P., Craft, J., Chu, E.W., Tralka, T.S. and Wilcox, J.L. Characteristics of an established cell line of retinoblastoma. J. Natl. Cancer Inst. 53:347-360.
15. 1974 Reid, T.W. and Russell, P. Recent observations regarding retinoblastoma: II. An enzyme study of retinoblastoma. Trans. Ophthalmol. Soc. U.K. 94:929-937. Ted W. Reid, Ph.D. 6 Rev 11-27-12 16. 1975 Craft, J., Albert, D.M. and Reid, T.W. Ultrastructural description of a "cylinder organelle" in the outer plexiform layer of human retinas. Invest. Ophth. 14:923-927.
17. 1976 Kass, M.A., Reid, T.W., Neufeld, A.H. Bausher, L.P. and Sears, M.L. The effect of d- isoproterenol on intraocular pressure of the rabbit, monkey and man. Invest. Ophth. 15:113-118.
18. 1976 Albert, D.M., Lahav, M., Bhatt, P.N., Reid, T.W., Ward, R.E., Cykiert, R.C., Lin, T.S., Ward, D.C. and Prusoff, W.H. Successful therapy of herpes hominis keratitis in rabbits by 5-iodo-5'-amino-2'5'-dideoxy-uridine (AIU). A novel analog of thymidine. Invest. Ophth. 15:470-478.
19. 1976 Reid, T.W., Russell, P. and Albert, D.M. Induction of the release of viral particles from Greene hamster melanoma cells by thymidine. In Pigment Cell, vol. 2, ed. V. Riley, pp. 22-30. Basel: S. Karger. (Proceedings of the X International Pigment Cell Conference, Part II, 1977, Cambridge, MA.)
20. 1977 Darling, T., Albert, J. Russell, P., Albert, D.M. and Reid, T.W. Rapid purification of an RNA tumor virus and proteins by high-performance steric exclusion chromatography on porous glass bead columns. J. Chromatography 131:383-390.
21. 1977 Dryja, T.P., Albert, D.M., Rosengren, E. and Reid, T.W. Presence of cysteinyldopa in the mature bovine eye. Exp. Eye Res. 25:459-464.
22. 1979 Gregerson, D.S. and Reid, T.W. Hamster melanoma virus: a unique retrovirus. In Pigment Cell, vol. 5, ed. S.N. Klaus, pp. 129-135. Basel: S. Karger. (Proceedings of the X International Pigment Cell Conference, Part II, 1977, Cambridge, MA.)
23. 1979 Darling, T.L. and Reid, T.W. Apparent allosterism by avian myeloblastosis virus reverse transcriptase and E. coli DNA polymerase I. Nucl. Acids Res. 6:1189-1202.
24. 1979 Gregerson, D.S., Russell, P. and Reid, T.W. Biochemical and immunological properties of the reverse transcriptase associated with a hamster retrovirus. J. Gen. Virol. 43:327-337.
25. 1979 Russell, P., Gregerson, D.S., Albert, D.M. and Reid, T.W. Characteristics of a retrovirus associated with a hamster melanoma. J. Gen. Virol. 43:317-326.
26. 1980 Gregerson, D.S., Albert, J. and Reid, T.W. Processive nature of reverse transcription by avian myeloblastosis virus deoxyribonucleic acid polymerase. Biochemistry 19:301-306.
27. 1980 Gregerson, D.S. and Reid, T.W. Properties of the reverse transcription of synthetic and hamster retroviral RNA by avian and hamster viral polymerases. Biochem. & Biophys. Res. Comm. 93:720-728.
28. 1980 Ljunggren, B., Carter, D.M., Albert, J. and Reid, T.W. Plasma levels of 8- methoxypsoralen determined by high-pressure liquid chromatography in psoriatic patients ingesting drug from two manufacturers. J. Invest. Dermatology 74:59-62. Ted W. Reid, Ph.D. 7 Rev 11-27-12 29. 1981 Gilbert, F., Balaban, G., Breg, W.R., Gallie, B., Reid, T. and Nichols, W. Homogeneously staining region in a retinoblastoma cell line: relevance to tumor initiation and progression. J. Natl. Cancer Institute 67:301-306.
30. 1981 Pahuja, S.L, Albert, J. and Reid, T.W. Use of reversed-phase high-performance liquid chromatography for simultaneous determination of glutamine synthetase and glutamic acid decarboxylase in crude extracts. J. Chrom. 225:37-45.
31. 1981 Rubin, N.A., Tarsio, J.F., Borthwick, A.C., Gregerson, D.S. and Reid, T.W. Identification and characterization of a growth factor secreted by an established cell line of human retinoblastoma maintained in serum-free medium. Vision Res. 21:105-112.
32. 1982 Pahuja, S.L. and Reid, T.W. Radioisotope assay for glutamine synthetase using thin- layer chromatography. J. Chrom. 235:249-255.
33. 1983 Pahuja, S.L. and Reid, T.W. A simple microassay for glutamic acid decarboxylase by ion exchange thin-layer chromatography. J. Liquid Chromat. 6(1): 127-137.
34. 1983 Pahuja, S.L. and Reid, T.W. Thin-layer chromatographic determination of L- asparaginase in the presence of human serum. J. Chrom. 273:431-435.
35. 1983 Tarsio, J.F., Rubin, N.A., Russell, P., Gregerson, D.S. and Reid, T.W. Growth stimulatory effects of retinoblastoma derived growth factors and other mitogens in Nakano mouse lens epithelial cells. Exp. Cell Res. 146:71-78.
36. 1984 Jones, T.R. and Reid, T.W. Trace elements in the eye. In Handbook of Experimental Pharmacology, ed. M.L. Sears, pp. 667-685. Berlin: Springer-Verlag.
37. 1984 Jones, T.R. and Reid, T.W. Sodium orthovanadate stimulation of DNA synthesis in Nakano mouse lens epithelial cells in serum-free medium. J. Cellular Physiology 121:199-205.
38. 1984 Pahuja, S.L., Albert, J. and Reid, T.W. Use of an optimum wavelength to detect glutamic acid and its metabolites in human serum by reversed phase HPLC. J. Liquid Chromatogr. 7:2261.
39. 1985 Pahuja, S.L., Mullins, B.T. and Reid, T.W. Bovine retinal glutamine synthetase 1. Purification characterization and immunological properties. Exp. Eye Res. 40:61-74.
40. 1985 Pahuja, S.L. and Reid, T.W. Bovine retinal glutamine synthetase 2. Regulation and properties on the basis of glutamine synthetase and glutamyl transferase reactions. Exp. Eye Res. 40:75-83.
41. 1986 Jones, T.R., Antonetti, D.L. and Reid, T.W. Aluminum ions stimulate mitosis in murine cells in tissue culture. J. Cellular Biochemistry 30:31-39.
42. 1986 Potluri, V.R., Helson, L., Ellsworth, R.M., Reid, T.W. and Gilbert, F. Chromosomal abnormalities in human retinoblastoma - a review. Cancer Ted W. Reid, Ph.D. 8 Rev 11-27-12 58:663-671.
43. 1986 Pansky, B., Das, A., Budd, G.C. and Reid, T.W. Insulin-like immunoreactivity in human retinoblastoma Y79 cell-line. Neurosci. L. 68:187-191.
44. 1987 Gentleman, S., Reid, T.W. and Martensen, T.M. Vanadate stimulation of phosphotyrosine protein levels in quiescent Nakano mouse lens cells. Exp. Eye Res. 44:587-594.
45. 1987 Reid, T.W. and Reid, W.A. The labile nature of the insulin signal(s) for the stimulation of DNA synthesis in mouse lens epithelial and 3T3 cells. J. Biol. Chem. 262:229-233.
46. 1987 Russell, P., Zelenka, P., Martensen, T. and Reid, T.W. Identification of the EDTA- extractable protein in lenses as calpactin I. Current Eye Res. 6:533-538.
47. 1990 Cullor, J.S., Mannis, M.J., Murphy, C.J., Smith, W.L., Selsted, M.E. and Reid, T.W. In vitro antimicrobial activity of defensins against ocular pathogens. Arch. Ophthalmol. 108:861-864.
48. 1991 Das, A., Pansky, B., Budd, G.C. and Reid, T.W. Human retinoblastoma Y79 cells contain both insulin-specific mRNA and insulin-binding sites. Neurosci. L. 121:231-3.
49. 1992 Schwab, I.R., Dries, D., Cullor, J.S., Smith, W.L., Mannis, M.J., Reid, T.W. and Murphy, C. Corneal storage medium preservation with defensins. Cornea 11:370-375.
50. 1993 Murphy, C.J., Foster, B.A., Mannis, M.J., Selsted, M. and Reid, T.W. Defensins are mitogenic for epithelial cells and fibroblasts. J. Cellular Phys. 155:408-413.
51. 1993 Reid, T.W., Murphy, C.J., Iwahashi, C.K., Foster, B.A. and Mannis, M.J. The stimulation of epithelial cell growth by the neuropeptide Substance P. J. Cellular Biochem. 52:476-485.
52. 1994 Villablanca, A., Murphy, C. and Reid, T.W. Growth-Promoting Effects of Substance P on Endothelial Cells in Vitro. Circulation Research. 75(6): 1113-1120.
53. 1994 Reid, T.W. Growth control of cornea and lens epithelial cells. Progress in Retinal and Eye Research, 13(2): 507-554.
54. 1994 Dushku, N. and Reid, T.W. Immunohistochemical Evidence that Pterygia Arise From Altered Limbal Epithelial Basal Stem Cells. Current Eye Research 13: 473-481.
55. 1995 Birney, D.M., Cole D.C., Crosson, C.E., Kahl, B.F., Neff, B.W., Reid, T.W., Ren, K. and Walkup, R.D. The Use of -Methylphenylalanine (MeF) Residues to Probe the Nature of the Interaction of Substance P With its Receptor: Effects of MeF-Containing Substance P Analogs on Rabbit Iris Smooth Muscle Contraction J. Med. Chem. 38: 2478-2482.
56. 1995 Kahl, B. and Reid, T.W. Substance P and the Eye. Progress in Retinal and Eye Research, 14(2): 473-504. Ted W. Reid, Ph.D. 9 Rev 11-27-12 57. 1996 Reid, T.W. and Dushku, N. Pterygia and Limbal Epithelial Cells: Relationship and Molecular Mechanisms. Progress in Retinal and Eye Research, 15(2): 297-329.
58. 1996 Nishida, T., Nakamura, M., Ofuji, K., Reid, T.W., Mannis, M. and Murphy, C.J. Synergistic Effects of Substance P with Insulin-Like Growth Factor on Epithelial Migration of the Cornea. J. Cellular Physiology 169:159-166.
59. 1997 Brown, S., Lamberts, D. Reid, T., Nishida, T., Murphy, C. Neurotrophic and Anhidrotic Keratopathy Treated with Substance P and Insulin Like Growth Factor, Archives Ophthalmology 115: 926-927.
60. 1997 Nakamura, M., Nishida, T., Ofuji, K., Reid, T.W., Mannis, M.J. and Murphy, C.J. Synergistic Effects of Substance P with Epidermal Growth Factor on Epithelial Migration in Rabbit Cornea, Exp. Eye Res. 65:321-329.
61. 1997 Villablanca, A.C. and Reid, T.W. Substance P Stimulates Vascular Endothelial Cellular Reducing Capacity in the Presence of Insulin and Human Plasma Factors, J. Cellular Biochemistry 66:471-481.
62. 1997 Dushku, N. and Reid, T.W. P53 Expression in Altered Basal Cells of Pingueculae, Pterygia, and Limbal Tumors, Current Eye Research 16: 1179-1192.
63. 1997 Nishida, T., Nakamura, M., Konma T., Ofuji, K., Nagano, K., Tanaka, T., Enoki, M., Reid, T.W., Brown, S.M., Murphy, C.J., Mannis, M.J. Neurotrophic keratopathy - studies on substance P and the clinical significance of corneal sensation. Nippon Ganka Gakkai Zasshi 101:948-974.
64. 1998 Spallholz, J., Reid, T.W., Boylan, M., Shriver, B. Selenium Free Radical Chemistry: Applications for Pharmaceuticals, STDA Sixth International Symposium 6: 47-56.
65. 1998 McDermott, A.M., Kern, T.S., Reid, T.W., Russell, P. and Murphy, C.J. Effect of substance P, insulin-like growth factor-1 and vasoactive intestinal polypeptide on corneal re-epithelialization I galactosemic rats. Curr. Eye Res. 17:1143-1149.
66. 1999 Dushku, N., Hatcher, S., Albert, D., and Reid, T.W. P53 expression and relation to human papillomavirus infection in pingueculae, pterygia, and limbal tumors. Arch. Ophth. 117:1593-1599.
67. 1999 Reid, T.W., Opolski, M.P. and Spallholz, J.E. Organo-Selenium Molecules Covalently- Attached to a Surface Block Biofilm Formation. SurFACTS 4(2): 6-7.
68. 2001 Dushku, N., Molykutty, K, Schultz, G. and Reid, T.W. Pterygia pathogenesis: Corneal invasion by MMP Expressing altered limbal epithelial basal cells. Arch. Ophth. 119:695-706.
69. 2001 Bentley E, Abrams GA, Covitz D, Cook CS, Fischer CA, Hacker D, Stuhr CM, Reid TW, Murphy CJ. Morphology and Immunohistochemistry of Spontaneous Chronic Corneal Epithelial Defects (SCCED) in Dogs. Invest Ophthalmol Vis Sci. 42;2262-2269. Ted W. Reid, Ph.D. 10 Rev 11-27-12 70. 2001 Murphy CJ, Marfurt CF, McDermott A, Bentley E, Abrams GA, Reid TW, Campbell S. Spontaneous Chronic Corneal Epithelial Defects (SCCED) in Dogs: Clinical Features, Innervation, and Effect of Topical SP, with or without IGF-1. Invest Ophthalmol Vis Sci. 42:2252-61.
71. 2001 Spallholz, J.E., Shriver, B.J., Reid, T.W. Dimethyldiselenide and methylseleninic acid generate Superoxide in an in vitro chemiluminescence assay in the presence of glutathione: implications for the anticarcinogenic activity of L-selenomethionine and L- Se-methylselenocysteine. Nutr. Cancer 40:34-41.
72. 2002 Lee, C.H., Whiteman, A.L., Murphy, C.J., Barney, N.P., Taylor, P.B. and Reid, T.W. Substance P, insulin-like growth factor I and surface healing. Arch Ophthalmol. 120:215-217.
73. 2002 Dushku, N., Molykutty, K, Schultz, G. and Reid, T.W. Republication of color figures: Pterygia pathogenesis: Corneal invasion by MMP Expressing altered limbal epithelial basal cells. Arch. Ophth. 120:234-237.
74. 2002 McAnulty JF, Reid TW, Waller KR, and Murphy CJ. Successful six-day kidney preservation using trophic factor supplemented media and simple cold storage. Am J Transplant. 2(8):712-8.
75. 2003 Reid, TW and Dushku, N. Does human papillomavirus cause pterygium? Br J Ophthalmol 87: 806-808
76. 2003 Reid, T.W., Tran, P., Spallholz, J. and Fralick, J. Counter Terrorism Measures to Combat Yersinia Pestis with Selenium Pharmaceuticals. Proceedings of the 2002 Joint Service Scientific Conference on Chemical and Biological Defense Research. 2003, 1- 7.
77. 2004 Spallholz, J.D., Palace, V.P. and Reid, T.W. Methioninase and selenomethionine but not Se-methylselenocysteine generate methylselenol and superoxide in an in vitro chemiluminescent assay: implications for the nutritional carcinostatic activity of selenoamino acids. Biochemical Pharmacology 67:547-554.
78. 2004 McAnulty JF, Foley JD, Reid TW, Heath TD, Waller KR, Murphy CJ. Suppression of cold ischemic injury in stored kidneys by the antimicrobial peptide bactenecin. Cryobiology;49(3):230-40.
79. 2004 Brown SM, Khanani AM, Stetson CL, Reid TW. Vesicular eruption in a child with trigeminal nerve palsy during topical therapy with substance P and insulin-like growth factor I for neurotrophic keratitis. Arch Ophthalmol. 2004 Nov;122(11):1722-3
80. 2005 Murray, B.E., Anderson, K.E. Arnold, K., Bartlett, J.G., Carpenter, C.C., Falkow, S., Hartman, J.T. Lehman, T., Reid, T.W., Ryburn, Jr., F.M., Sack, R.B., Struelens, M.J., Young, L.S., and Greenough III, W.B,, Destroying the Life and Career of a Valued Physician-Scientist Who Tried to Protect Us from Plague: Was It Really Necessary ? Clin Infect Dis 40:1644-1648 Ted W. Reid, Ph.D. 11 Rev 11-27-12
81. 2006 Schneider, B.G., John-Aryankalayil, M., Rowsey, J.J., Dushku, N., and Reid, T. Accumulation of p53 protein in pterygia is not accompanied by TP53 gene mutation. Exper. Eye Research 82: 91-98
82. 2006 John-Aryankalayil, M., Dushku, N., Jaworski, C., Cox, C., Schultz, G., Smith, J., Keri R., Dietrich S., Reid T., "Carper, D., Microarray and protein analysis of human pterygium. Mol Vis 12: 55-64.
83. 2006 McDermott, A.M., Rich, D., Cullor, J., Mannis, M., Smith, W., Reid, T.W., Murphy, C.J., “The in vitro activity of selected defensins against an isolate of Pseudomonas in the presence of human tears.” British J. Ophthalmology 90:609-611.
84. 2006 Mathews, S.M., Spallholz, J.E., Grimson, M.J., Dubielzig, R.R., Gray, T., Reid, T.W Prevention of bacterial colonization of contact lenses with covalently attached selenium and effects on the rabbit cornea. Cornea. 25:806-14.
85. 2007 Schneider, B.G., Sahni, D., Torres, J.C., Dushku, N., Reid, T.W. MLH1 and MSH2 Expression in Pterygia. Cornea 26:468-72.
86. 2008 Low, T., Jackson, A., Morse, A., Mosley, T., Reid, T.W., Selenium Coating of Water Distribution Tubing to Inhibit Biofilm, SAE International http://papers.sae.org/2008-01-2158
87. 2009 Tran, P.L., Hammond, A.A., Mosley, T., Janette Cortez, J., Gray, T., Colmer- Hamood, J.A., Shashtri, M., Spallholz, J.E., Hamood, A.N. and Reid, T.W. An Organo-Selenium Coating on Cellulose Inhibits Pseudomonas aeruginosa and Staphylococcus aureus Biofilm Formation. Applied and Environmental Microbiology 75: 3586-3592.
88. 2009 Pot, S.A., Chandler, H.L., Colitz, C.M., Bentley, E., Dubielzig, R.R., Mosley, T.W., Reid, T.W., & Murphy, C.J. Selenium functionalized intraocular lenses inhibit posterior capsule opacification in an ex vivo canine lens capsular bag assay. Experimental Eye Research. 89: 728-234.
89. 2009 Jaworski, C., Aryankalayil-John, M., Campos, M., Fariss, R. Rowsey, J., Agarwalla, N., Reid, T.W., Dushku, N., Cox, C., Carper, D., Wistow, G. Expression analysis of conjunctival and limbal markers and genes associated with cell migration. Mol. Vis. 20: 2421-34.
90. 2010 Reid, T., Tran, P., Cortez, J., Mosley, T., Shashtri, M., Spallholz, J., Pot, S. and Hamood., A. Medical Devices Coated with Organo-Selenium Inhibit Bacterial and Cellular Attachment. International Medical Devices 5: 23-31.
91. 2010 Bradley, J.C., Yang, W., Bradley, R.H., Reid, T.W., Schwab, I.R., The Science of Pterygia, Br J Ophthalmol 94:815-820
92. 2010 Cox CA, Amaral J, Salloum R, Guedez L, Reid TW, Jaworski C, John-Aryankalayil M, Freedman KA, Campos MM, Martinez A, P Becerra S, Carper DA. Doxycyclin’s Ted W. Reid, Ph.D. 12 Rev 11-27-12 Effect on Ocular Angiogenesis: An In Vivo Analysis. Ophthalmology. 117(9):1782- 91.
93. 2010 Reid, T. and Dushku, N. What a study of pterygia teaches us about the cornea? Molecular mechanism of formation. Eye Contact Lens. 36:290-5.
94. 2011 Reid, T., Tran, P., Mosley, T., Tran ,K Jarvis,C. Patel S., Shashtri, M., Haynes, R., and Hamood., A. Biopolymers Containing Selenium: Their Synthesis and Use. International Journal Medical Devices Vol 6, No.2
95. 2011 Low, D., Hamood, A., Reid, T.W., Mosley, T., Tran, P., Song, L. and Morse, A. Attachment of selenium to a reverse osmosis membrane in inhibit biofilm formation of S. aureus. J. Membrane Science On line 20 May 2011.
96. 2011 Toris, C.B., Gulati, V, Reid, T.W. and Quigley, H. Reflections on the career of Carl Camras. Expt. Eye Resch. 2011: 1-4.
97. 2011 Yang, W., Bradley, J.C. Reid, T.W. and McCartney, D. L. Growth factors in aqueous humor. Ophthalmology 118:1003-1003.
98. 2012 Tran, T., Lowry, N., Campbell, T., Reid, T. W., Webster, D., Tobin, E., Aslani, A., Mosley, T., Dertien, J., Colmer-Hamood, J., and Hamood, A. An Organoselenium Compound Inhibits Staphylococcus aureus Biofilms on Hemodialysis Catheters in Vivo. Antimicrobial Agents and Chemotherapy 56:972-978.
99. 2013 Vercellino, T, Morse, A, Tran, P, Song, L, Hamood, A, Reid, T, Moseley, T. Attachment of organo-selenium to polyamide composite reverse osmosis membranes to inhibit biofilm formation of S. aureus and E. coli. Desalination 309:291-295. Ted W. Reid, Ph.D. 13 Rev 11-27-12 SUBMITTED:
Zhang, Z, Penturf, M, Reid, T.W., Boylan, M., Spallholz, J., Griswald, J. The effect of Topical Application of Substance P or Selenocystamine on the Healing of Full Thickness Punch Wounds in the Rat. (resubmitted) Wound Healing
Kahl, B., Saban, R., Murphy, C., Bjorling, D., Birney, D., Walkup, R., and Reid, T.W., - Methylphenylalanine analogs of substance P: Indication of different functional subtypes of the NK-1 receptor (resubmitted). Peptides
Iwahashi, C. K., Pahuja, S. and Reid T. W. The effect of dexamethasone on DNA Synthesis in dependent upon cell type and growth factor. (Submitted) J. Cellular Physiology
Reid, T. W. and Hamill, V. The role of prostaglandins and leukotrienes as late signals for growth factor stimulation of DNA synthesis. (Submitted) J. Cellular Biochemistry.
Dushku, N. and Reid, T.W. Abnormal H-ras suppression and activation in the altered limbal basal cells (Pterygium Cells) of pterygia. (Submitted) Molecular Vision Ted W. Reid, Ph.D. 14 Rev 11-27-12 TEXTS:
1. 1971 Reid, T.W. and Wilson, I.B. E. coli alkaline phosphatase. In The Enzymes, vol. 4, pp. 373-415, ed. P.D. Boyer. New York: Academic Press.
2. 1976 Reid, T.W., Russell, P. and Albert, D.M. Induction of the release of viral particles from Greene hamster melanoma cell by thymidine. In Pigment Cell, vol. 2, ed. V. Riley, pp. 22-30. Basel: S. Karger. (Proceedings of IX International Pigment Cell Conference.)
3. 1979 Gregerson, D.S. and Reid, T.W. Hamster melanoma virus: a unique retrovirus. In Pigment Cell, vol. 5, ed. S.N. Klaus, pp. 129-135. Basel: S. Karger. (Proceedings of the X International Pigment Cell Conference, Part II, Cambridge, MA, 1977.)
4. 1984 Jones, T.R. and Reid, T.W. Trace elements in the eye. In Pharmacology of the Eye, vol. 69, ed. M.L. Sears, pp. 667. Berlin: Springer-Verlag.
5. 1994 Reid, T.W. Growth control of cornea and lens epithelial cells. In Progress in Retinal and Eye Research, vol. 13(2). 507-554. Osborne and Chader eds. Great Britain: Elsevier Science.
6. 1995 Kahl, B. and Reid, T.W. Substance P and the Eye. Progress in Retinal and Eye Research, 14(2): 473-504. Osborne and Chader eds. Great Britain: Elsevier Science.
7. 1996 Reid, T.W. and Dushku, N. Pterygia and Limbal Epithelial Cells: Relationship and Molecular Mechanisms. Progress in Retinal and Eye Research, 15(2): 297-329. Ted W. Reid, Ph.D. 15 Rev 11-27-12 ABSTRACTS:
1. Albert, D. M. and Reid, T. RNA-Dependent DNA-Polymerase in Retinoblastoma and Related Tumors. ARVO Conference, April 1972, Sarasota, Florida
2. Berger, R.O., Reid, T.W., Neufeld, A.H. and Sears, M.L. The Effects of Adrenergic Agents and Prostaglandins on an Isolated Iris Preparation. ARVO Conference, April 1973, Sarasota, Florida
3. Reid, T.W., Russell, P. and Albert, D.M. Biochemical Characteristic of an Established Cell Line of Retinoblastoma. ARVO Conference, April 1974, Sarasota, Florida
4. Albert, D.M., Reid, T.W., Rabson, A.S. and Chu, E.W. Morphologic and Cytogenetic Characteristics of an Established Cell Line of Retinoblastoma. ARVO Conference, April 1974, Sarasota, Florida
5. Lahav, M., Albert, D.M., Reid, T.W., Colby, E. and Shadduck, J. Ocular Neoplasia and Dysplasia Induced by Feline Sarcoma Virus. ARVO Conference, April 1975, Sarasota, Florida
6. Albert, D., Craft, J., DeLellis, R. and Reid, T. Neurosecretory Granules in a Retinoblastoma. ARVO Conference, April 1975, Sarasota, Florida
7. Albert, D., Lahav, M., Bhatt, P., Reid, T., Ward, D. and Prusoff, W. Successful Therapy of Herpes Virus Hominis Keratitis in Rabbits by 5'-Amino-2', 5'-Deoxy-5-Iodouridine (AIU). ARVO Conference, April 1975, Sarasota, Florida
8. Reid, T.W. and Albert, D.M. A Substrate Study of Glutamine Transferase from the Retina. ARVO Conference, April 1975, Sarasota, Florida
9. Albert, D.M., Gallie, B., Reid, T.W., Ryu, S. and Schwartz, E. Heterologous Transplantation of Ocular Melanomas and Retinoblastomas. ARVO Conference, April 1976, Sarasota, Florida
10. Reid, T.W., Dryja, T. and Albert, D.M. The Determination off 5-S-Cysteinyldopa Levels in the Eye. ARVO Conference, April 1976, Sarasota, Florida
11. Gregerson, D.S. and Reid, T.W. Type C-Like Virus Particle from Human Retinoblastoma Cells. ARVO Conference, April 1977, Sarasota, Florida
12. Pahuja, S. and Reid, T. Characteristics and Induction of Glutamine Synthetase in Retinal Cells. ARVO Conference, April 1978, Sarasota, Florida
13. Pahuja, S.L., Mullins, B.T. and Reid, T.W. Characterizations of Glutamine Synthetase from the Retina. ARVO Conference, April 1979, Sarasota, Florida
14. Rubin, N., Lee, M. -S., Gregerson, D.S. and Reid, T.W. Growth of a Retinal Tumor Cell Line in Tissue Culture without Serum. ARVO Conference, April 1979, Sarasota, Florida. Ted W. Reid, Ph.D. 16 Rev 11-27-12 15. Rubin, N.A., Borthwick, A.C., Albert, J., Gregerson, D.S. and Reid, T.W. Identification and Characterization of a Mitogenic Factor Secreted by an Established Cell Line of Human Retinoblastoma Maintained in Serum-Free Media. American Society for Cell Biology, November 1979, Toronto, Canada
16. Pahuja, S.L., Mullins, B.T. and Reid, T.W. A Comparison of Molecular and Kinetic Characteristics of Glutamine Synthetase from Brain Cells and Retinal Cells. American Society for Cell Biology, November 1979, Toronto, Canada
17. Pahuja, S.L. and Reid, T.W. A New Radioactive Method for Studying Kinetics of Retinal Glutamine Synthetase. ARVO Conference, May 1980, Orlando, Florida
18. Tarsio, J.F., Gregerson, D.S., Russell, P. and Reid, T.W. Secretion of a Growth Promoting Activity for Nakano Mouse Lens Epithelial Cells by a Human Retinoblastoma Cell Line. ARVO Conference, May 1980, Orlando, Florida
19. Rubin, N.A., Gregerson, D.S. and Reid, T.W. Retinoblastoma-derived Growth Factor (RDGF), a Mitogenic Factor Secreted by an Established Human Retinoblastoma Cell Line (Y-79). ARVO Conference, May 1980, Orlando, Florida
20. Rubin, N.A., Gregerson, D.S. and Reid, T.W. Identification and Characterization of a Growth Factor (RDGF) Secreted by an Established Cell Line of Human Retinoblastoma Cells (Y-79). Fifth SOVD, June 9-10, Temple University, Philadelphia, Pennsylvania
21. Tarsio, J.F., Gregerson, D.S., Russell, P. and Reid, T.W. Secretion of a Growth Promoting Activity for Nakano Mouse Lens Epithelial Cells by a Human Retinoblastoma Cell Line. Fifth SOVD, June 9-10, 1980, Temple University, Philadelphia, Pennsylvania
22. Tarsio, J.F., Rubin, N.A., Gregerson, D.S., Russell, P. and Reid, T.W. Secretion of a Growth Promoting Activity for Nakano Mouse Lens Epithelial Cells by a Human Retinoblastoma Cell Line. American Society for Cell Biology, November 14-18, 1980, Cincinnati, Ohio
23. Rubin, N.A., Tarsio, J.F., Gregerson, D.S. and Reid, T.W. Identification and Characterization of a Growth Factor Secreted by an Established Cell Line (Y-79) of Human Retinoblastoma Maintained in Serum-Free Medium. American Society for Cell Biology, November 14-18, 1980, Cincinnati, Ohio
24. Pahuja, S.L. and Reid, T.W. A simple and Sensitive Method for Asparaginase. American Society for Cell Biology, November 14-18, 1980, Cincinnati, Ohio
25. Pahuja, S.L., Mullins, B.T., Lee, M.S. and Reid, T.W. Regulation of Glutamine Synthetase by Insulin and Glutamine in Retinal Tumor Cells. American Society for Cell Biology, November 14-18, 1980, Cincinnati, Ohio
26. Tarsio, J.F., Poirier, D.L., Gregerson, D.S. and Reid, T.W. Effect of Retinoblastoma Derived Growth Factor and Other Mitogens on the Growth of Lens and 3T3 Cells in Culture. ARVO Conference, April 27 to May 1, 1981, Sarasota, Florida
27. Czako-Herskovic, M., Golde, W., Stein, P.J., Sorbi, R.T., Pahuja, S.L. and Reid, T.W. Role of the Retinal Rod Outer Segment Membrane in the Biosynthesis of Rhodopsin: A Ted W. Reid, Ph.D. 17 Rev 11-27-12 Monoclonal Antibody Approach. American Society for Cell Biology, November 9-13, 1981, Anaheim, California
28. Reid, T.W. and Antonetti, D.L. Characteristics of a Human Retinoblastoma Cell Line Growing Totally Serum Free: Effects of the Addition of Other Factors. ARVO Conference, May 2-7, 1982, Sarasota, Florida
29. Reid, T.W., Pahuja, S.L., Albert, J. and Mullins, B.T. Purification and Characterization off Retinoblastoma Derived Growth Factor Based upon Its Self-Association. American Society for Cell Biology, November 30, 1982, Baltimore, Maryland
30. Jones, T.R. and Reid, T.W. DNA Synthesis in Cultured Lens Cells by Ortho Vanadate. ARVO, May 1, 1983, Sarasota, Florida
31. Pahuja, S.L. and Reid, T.W. Multiple Molecular Forms and Properties of Purified Retinoblastoma Derived Growth Factor. ARVO, May 1, 1983, Sarasota, Florida
32. Reid, T.W. and Pahuja, S.L. Mechanisms of Action of Retinoblastoma Derived Growth Factor on Lens Epithelial Cells - Role of Aggregation. American Society for Cell Biology, November 29, 1983, San Antonio, Texas
33. Reid, T.W. and Pahuja, S.L. Cell Surface Aggregation of Retinoblastoma Derived Growth Factor (RDGF) on Lens Epithelial Cells. ARVO, April 29, 1984, Sarasota, Florida
34. Pahuja, S.L. and Reid, T.W. Synergism between Insulin and Retinoblastoma Derived Growth Factor for the Stimulation of DNA Synthesis in Lens Epithelial Cells. ARVO, April 29, 1984, Sarasota, Florida
35. Graupner, G.A., Bialasiewicz, A.A., Salowski, A.B. and Reid, T.W. Lectin Binding Patterns of Human Retinoblastoma Cell Lines and Retinal Pigment Epithelial Cells. ARVO, April 29, 1984, Sarasota, Florida
36. Jones, T.R., Antonetti, D.L. and Reid, T.W. Aluminum Induces Mitosis in Nakano Mouse Lens Epithelial Cells. ARVO, April 29, 1984, Sarasota, Florida
37. Lee, M.S. and Reid, T.W. DNA-Mediated Transfer of Retinoblastoma Genes into Mouse L Cells. ARVO, April 29, 1984, Sarasota, Florida
38. Gentleman, S. and Reid, T.W. Vanadate Enhances Phosphotyrosine Protein Levels in Nakano Lens Cells. Federation of American Societies for Experimental Biology, April 21, 1985, Anaheim, California
39. Lee, M.S., Dryja, T.P., Albert, D.M. and Reid, T.W. Retinoblastoma Derived Growth Factor Is Not A N-Myc Gene Product. ARVO, May 8, 1985, Sarasota, Florida
40. Reid, T.W. and Pahuja, S. Protection Against the Effects of Dexamethasone on Murine Lens Epithelial Cells by Transient Exposure to RDGF. ARVO, May 8, 1985, Sarasota, Florida
41. Reid, T.W. The Transient Nature of the Insulin Second Messenger. UCLA Molecular Biology Symposium, April 6, 1986, Steamboat Springs, Colorado Ted W. Reid, Ph.D. 18 Rev 11-27-12
42. Lee, M.S., Albert, D.M. and Reid, T.W. A New Protein Induced by Retinoblastoma Derived Growth Factor. ARVO, April 28, 1986, Sarasota, Florida
43. Reid, T.W. and Reid, W.A. The Insulin Second Messenger for the Stimulation of DNA Synthesis in Lens Epithelial Cells. ARVO, April 28, 1986, Sarasota, Florida
44. Reid, T.W., Gentleman, S., Martensen, T. and Kon, H. Vanadate and Insulin Synergism in the Stimulation of DNA Synthesis and Tyrosine Phosphorylation. American Society of Cell Biology and American Chemical Society, June 9, 1986, Washington, D.C.
45. Lee, M.S., McGee, T. and Reid, T.W. Transfer of Retinoblastoma Derived Growth Factor Gene to Mouse L Cells. ARVO, May 4-8, 1987, Sarasota, Florida
46. Reid, T.W. and Hamill, V. Leukotrienes' Roles as Late Signals for Growth Factor Stimulation of DNA Synthesis. ARVO, May 4-8, 1987, Sarasota, Florida
47. Reid, T.W. and Lee, R. Aluminum Effects on Mitosis in Lens Epithelial Cells Occur After Cells Leave G1/G0. ARVO, May 2-6, 1988, Sarasota, Florida
48. Reid, T.W. and Foster, B. Factors Which Influence the Growth of Retinoblastoma Cells (Y- 79) in Culture. 8th International Congress of Eye Research, September 40-8, 1988, San Francisco, California
49. Foster, B., Murphy, C., Cullor, J., Selsted, M., Mannis, M. and Reid, T.W. The Stimulation of DNA Synthesis and Cell Growth in Lens Epithelial Cells by Human and Rabbit Defensins. 8th International Congress of Eye Research, September 4-8, 1988, San Francisco, California
50. Mannis, M., Cullor, J., Murphy, C., Selsted, M. and Reid, T. The Use of Defensins for the Eradication of Ocular Pathogens in Vitro. Annual Meeting of the Ocular Microbiology and Immunology Groups, October 7, 1988, Las Vegas, Nevada
51. Iwahashi, C.K. and Reid, T.W. Clones of Lens Epithelial Cells That Show Both Negative and Positive Stimulation of DNA Synthesis by Dexamethasone. American Society for Cell Biology, Jan. 29-Feb. 2, 1989, San Francisco, California
52. Foster, B. and Reid, T.W. Mechanistic Studies on the Aluminum Stimulation of DNA Synthesis in Late G1/G0. American Society for Cell Biology, Jan. 29-Feb. 2, 1989, San Francisco, California
53. Reid, T. and Iwahashi, C. The Modulation of Dexamethasone Inhibition of Lens Epithelial Cell Growth by Different Growth Factors. ARVO, April 30-May 5, 1989, Sarasota, Florida
54. Murphy, C.J., Foster, B., Mannis, M., Cullor, J., Selsted, M. and Reid, T. The Stimulation of Ocular Cell Growth by Defensins of Human and Rabbit Origin. ARVO, April 30-May 5, 1989, Sarasota, Florida Ted W. Reid, Ph.D. 19 Rev 11-27-12 55. Foster, B.A., Murphy, C.J., Mannis, M. and Reid, T.W. The Antimicrobial Peptides - Defensins - Stimulate Ocular Cell Growth. Western Eye Research Conference, October 7- 10, 1989, Government Camp, Oregon
56. Foster, B.A. and Reid, T.W. Modulation of Dexamethasone Mediated Inhibition of EGF- Stimulated Cell Growth by Amplification of EGF-Receptors in NIH 3T3 Cells. UCLA Molecular Biology Symposium, January 29-February 2, 1990, Keystone, Colorado
57. Reid, T.W., Murphy, C.J., Iwahashi, C., Malfroy, B. and Mannis, M.J. The Stimulation of DNA Synthesis in Epithelial Cells by Substance P and CGRP. ARVO, April 28-May 4, 1990, Sarasota, Florida
58. Murphy, C.J., Mannis, M.J., Malfroy, B. and Reid, T.W. Neuropeptide Depletion Impairs Corneal Epithelial Wound Healing. ARVO, April 28-May 4, 1990, Sarasota, Florida
59. Mannis, M.J., Murphy, C., Reid, T.W. and Iwahashi, C. The role of Neuropeptides in the Genesis and Treatment of Corneal Ulcers. Castroviejo Cornea Society, October 27, 1990, Atlanta, GA
60. Villablanca, A.C. and Reid, T.W. Substance P Stimulates Proliferation of Bovine Aortic Endothelial Cells in Serum-Free Culture. UCLA Molecular Biology Symposium, April 1- April 7, 1991, Keystone, Colorado
61. Plotnik, R.D., Mannis, M.J., Schwab, I.R., Cullor, J., Jan, B., Iwahashi, C., Reid, T.W. and Murphy, C.J. Gel Cyanoacrylate: Corneal Bonding Characteristics, Cell Toxicity, and Antimicrobial Properties. ARVO, April 28-May 4, 1991, Sarasota, Florida
62. Mannis, M.J., Schwab, I.R., Dries, D., Cullor, J., Smith, W., Reid, T.W. and Murphy, C.J. Defensins as a preservative in Corneal Storage Medium. ARVO, April 28-May 4, 1991, Sarasota, Florida
63. Murphy, C.J., Mannis, M.J. and Reid, T.W. Enkephalinase Decreases Lens Regeneration in Aphakic Rabbits. ARVO, April 28-May 4, 1991, Sarasota, Florida
64. Reid, T.W., Murphy, C.J., Iwahashi, C.K. and Mannis, M.J. Mechanism of Stimulation of DNA Synthesis and Cell Growth in Epithelial Cells by Substance P. ARVO, April 28- May 4, 1991, Sarasota, Florida
65. Teplitz, R.L., Roth, A., Albert, D., Reid, T.W., Schultz, D. and Butler, B.B. Is retinoblastoma heterogeneity multigenic? 8th International Congress of Human Genetics. October 6-11, 1991, Washington D.C.
66. Nishida, T., Nakamura, M., Mishima, H., Otori, T., Reid, T.W., Murphy, C.J. and Mannis, M.J. Synergistic Effects of Substance P with Epidermal Growth Factor and Insulin-Like Growth Factor on Corneal Epithelial Migration in Culture. ARVO, April 28-May 4, 1992, Sarasota, Florida
67. Villablanca, A.C. and Reid, T.W. Nicotine effects on endothelial cell growth. UCLA Molecular Biology Symposium, January 13-19, 1992, Keystone, Colorado Ted W. Reid, Ph.D. 20 Rev 11-27-12 68. Reid, T.W., Murphy, C.J. and Crosson, C.E. Mechanistic Studies on the Stimulation of DNA Synthesis and Cell Growth in Epithelial Cells by Substance P ARVO, April 28-May 4, 1992, Sarasota, Florida
69. Murphy, C.J., Jaynes, J., Iwahashi, C., Cullor, J., Reid, T.W., Mannis, M.J. and Schwab, I.R. The Modulation of Ocular Cell Growth by Cecropins. ARVO, April 28-May 4, 1992, Sarasota, Florida
70. Walkup, R.D., Birney, D.M., Reid, T.W., Crosson, C.E., Cole, D.C. and Wagenseller, E.P. The bis- phenylalanine moiety of substance P: Evaluation of synthetic analogues for the modulation of epithelial cell growth. Keystone Symposia, Mar 8-14, 1993, Taos, New Mexico.
71. Dushku, N., Tyler, N. and Reid, T.W. Immunohistochemical Evidence that Pterygia Arise from Altered Limbal Epithelial Basil Stem Cells. ARVO, May 2-7, 1993, Sarasota, Florida
72. Reid, T.W., Murphy, C.J., Crosson, C.E. and Johnson, M. The Substance P Receptor for Cell Growth is not the same as the One for Smooth Muscle Contraction. ARVO, May 2-7, 1993, Sarasota, Florida
73. Birney, D.M., Cole, D.C., Kahl, B.F., Reid, T.W., Wagenseller, E.P. and Walkup, R.D. Substance P bearing phenylalanine analogs: The effects of subtle spatial differences upon substance P's ability to stimulate smooth muscle contraction and epithelial cell growth. Gordon Conference: Biopolymers, February 14-18, 1994, Ventura, CA.
74. Walkup, R.D., Birney, D.M., Cole, D.C., Kahl, B.F., Reid, T.W. and Wagenseller, E.P. Substance P bearing phenylalanine analogs: The effects of subtle spatial differences upon substance P's ability to stimulate smooth muscle contraction and epithelial cell growth. American Chemical Society, March 13-17, 1994, San Diego, California
75. Nakamura, M., Nishida, T., Reid, T.W. and Murphy, C.J. Substance P (SP) enhances EGF stimulated corneal epithelial cell migration, however this action of SP is not mediated by the NK-1 or NK-2 receptors. ARVO, May 1-6, 1994, Sarasota, Florida
76. Reid, T.W., Kahl, B.F., Crosson, C.E., Walkup, R.D., Cole, D.C., Birney, D.M., Wagenseller, P.E. and Murphy, C. Substance P (SP): Effects of subtle spatial changes in the phenylalanine residue on SP's ability to stimulate iris smooth muscle contraction. ARVO, May 1-6, 1994, Sarasota, Florida
77. Dushku, N. and Reid, T.W. Immunohistochemical evidence that pterygia originate from p53 expressing transformed limbal epithelial basal stem cells. ARVO, May 1-6, 1994, Sarasota, Florida
78. Reid, T.W., Kahl, B.F., Birney, D.M., Walkup, R.D., Ren, K., Cole, D.C. and Neff, B.W. Methyl substitution on the -carbon of the phenylalanines of substance P (SP) to probe the nature of SP's interaction with its receptor. American Society for Cell Biology, December, 1994, San Francisco California.
79. Chen, J.J., Reid, T.W., Boylan, L.M. and Spallholz, J.E. Evaluation of selenite toxicity on two lines of human ovarian tumor cells NIH: OVCAR-3 and A2780 cells. FASEB Experimental Biology April 9-13, 1995, Atlanta, Georgia Ted W. Reid, Ph.D. 21 Rev 11-27-12
80. Boylan, L.M., Spallholz, J.E., Morales, J. and Reid, T.W. The use of selenium covalently attached to a cellulose sponge to inactivate growth factors as measured by the stimulation of epithelial cell growth. FASEB Experimental Biology April 9-13, 1995, Atlanta, Georgia
81. Morales, J., Boylan, L., Spallholz, J., Murphy, C., Dubielzig, R. and Reid, T. Selenium used to modulate wound healing after glaucoma filtration surgery in the rabbit model. ARVO, May 14- 19, 1995, Ft. Lauderdale, Florida.
82. Kahl, B., Birney, D., Walkup, R., Ren, K., Cole, D., Neff, B. and Reid, T. The rabbit ocular substance P (SP) receptor: The use of methyl substitution on the -carbon of the phenylalanines of SP analogs to probe the nature of the SP/receptor interaction. ARVO, May 14-19, 1995, Ft. Lauderdale, Florida.
83. Murphy, C., Russell, P. and Reid, T. Substance P accelerates corneal epithelial wound healing of galactose rats. ARVO, May 14-19, 1995, Ft. Lauderdale, Florida.
84. Dushku, N. and Reid, T. Immunohistochemical evidence that pterygia originate from Rb and TGF expressing, p53 transformed limbal basal stem cells. ARVO, May 14-19, 1995, Ft. Lauderdale, Florida.
85. Reid, T., Kahl, B., Birney, D., Walkup, R., and Ren, K. The use of Methyl Substitution of the - carbon of the phenylalanines of substance P (SP) analogs to Probe the Nature of the SP Receptor Subtypes. Tachykinins '95, October 16-18, 1995, Florence, Italy.
86. Jones, J., Chen, L., Straub, M., Butterick, C., Morrow, K.J., Reid, T., and Spallholz, J. Conjugation of Selenium to a Monoclonal Prostate Tumor Antibody 7E11:Superoxide Generation, ELISA Assay and In Vitro Cytotoxicity. Keystone, January 29-Feb 1, 1996, Taos, New Mexico.
87. Kahl, B.F., Reid, T.W., Walkup, R.D., Cole, D.C., Birney, D.M., Ren, K. The use of methyl substitution of the -carbon of the phenylalanines of substance P (SP) analogs to probe the nature of the SP receptor subtypes in ocular tissue. Western Eye Research Conference, February 22-25, 1966, Boerne, Texas.
88. Griffith, S., McCartney, D., Steward, K., Murphy C., Mannis M., and Reid, T. Effects of the Bovine Neutrophil Antibiotic Dodeca-Peptide (BNP-1) on the Growth of Human Corneal Endothelial Cells in Optisol and Tissue Culture Media. Eye Bank Association of Texas Meeting, March 2, 1996, Austin, Texas.
89. Nakamura, M., Nishida, T., Ofuji, K., Reid, T., Murphy, C., and Mannis, M., Synergistic Effect of Substance P with Epidermal Growth Factor on Corneal Epithelial Migration. World Congress in Cornea. April 18-19, 1996, Ft. Lauderdale, Florida.
90. Straub, M.J., Chen, L., Butterick, C., Morrow, K.J., Jones, J.A., Reid, T.W. and Spallholz, J. Selenium-conjugate induced prostate cancer cell cytotoxicity. 87th Annual Meeting of American Association for Cancer Research, April 20-24, 1996, Washington, D.C.
91. Reid, T.W. The role of basement membrane in ocular epithelial cell p53 expression and limbal stem cell migration. 2nd Ocular Surface and Tear Workshop, April 20, 1996, Miami, Florida. Ted W. Reid, Ph.D. 22 Rev 11-27-12 92. Reid, T.W., Saban, R., Bjorling, E.E., Kahl, B.F., Birney, D.M., Walkup, R.D., Ren, K. and Murphy, C.J. The use of methyl substitution of the -carbon of the phenylalanines of substance P (SP) analogs to probe the nature of the SP/receptor interaction. ARVO, April 21-26, 1996, Ft. Lauderdale, Florida.
93. Griffith, S.A., McCartney, D.L., Murphy, C.J., Mannis, M.J. and Reid, T.W. Effect of the bovine neutrophil antibiotic dodeca-peptide (BNP-1) on the growth of human corneal endothelial cells in Optisol and tissue culture media. ARVO, April 21-26, 1996, Ft. Lauderdale, Florida.
94. Dushku, N. and Reid, T.W. Basement membrane dependent P53 expression in limbal-corneal epithelia of pingueculae, pterygia, limbal tumors and normal eyes. ARVO, April 21-26, 1996, Ft. Lauderdale, Florida.
95. Lee, C.H., Nelson, M., Barney, N.P., Brightbill, F.S., Araki-Sasaki, K., Reid, T. and Murphy, C.J. Migration and proliferation characteristics of SV-40 transformed human corneal epithelial cells in response to neuropeptides. ARVO, April 21-26, 1996, Ft. Lauderdale, Florida.
96. Reid, T.W., Kahl, B.F., Walkup, R.D., Birney, D.M., Ren, K. Methyl substitution of the - carbon on the phenylalanines of substance P (SP) as probes to the nature of the SP receptor subtypes. Protein Society, August 3-7, 1996, San Jose, California.
97. Spallholz, J.E., Chen, L., Reid, T., Jones, J., Straub, M., Morrow, J. and Butterick, C. Covalent free radical chemistry of selenium immuno-conjugates and their potentially useful pharmaceutical applications. Sixth International Symposium on Selenium in Biology and Medicine, August 18- 22, 1996, Beijing, China.
98. Reid, T.W., Boylan, L.M., Spallholz, J.E., Graham, S., Murphy, C.J., Dubielzig, R.R., Shetlar, M. and Morales, J. The ability of selenium covalently attached to an inert cellulose matrix to modulate fibrosis by growth factor inactivation. Sixth International Symposium on Selenium in Biology and Medicine, August 18-22, 1996, Beijing, China.
99. Dushku, N. and Reid, T.W. Basement membrane dependent p53 and Rb expression in limbal-corneal epithelia of pingueculae, pterygia, limbal tumors and normal eyes. American Society for Cell Biology, December 7-11, 1996, San Francisco, California.
100. Spallholz, J.E., Boylan, M., Reid, T.W. and Chen, L. In vitro and in vivo cytotoxicity of a B72.3 Mab-Se immunoconjugate against LS174T Colon Tumor Cells. FASEB Experimental Biology April 6-9, 1997, New Orleans, Louisiana.
101. Chen, L., Boylan, M., Reid, T.W. and Spallholz, J.E. Cytotoxicity of an internalizing 7E11-C5 Mab- Se immunoconjugate against DU145 prostate tumor cells. FASEB Experimental Biology April 6-9, 1997, New Orleans, Louisiana.
102. Reid, T.W., Boylan, L.M., Spallholz, J.E. and Morales, J. Selenium covalently attached to an inert cellulose matrix modulates cellular growth in vitro by growth factor inactivation. FASEB Experimental Biology April 6-9, 1997, New Orleans, Louisiana.
103. Dushku, N., Albert, D.M. and Reid, T.W. Classification of P53 Expression in Limbal Cells of Pingueculae, Pterygia, and Premalignant and Malignant Limbal Tumors. ARVO, May 11-16, 1997, Ft. Lauderdale, Florida. Ted W. Reid, Ph.D. 23 Rev 11-27-12
104. Spallholz, J.E., Reid, T.W., and, Richard, W., Selenium Immunoconjugate Therapeutics. IBC Symposium on Antibody-Based Therapeutics, June 5-6, 1997, Boston, Massachusetts.
105. Reid, T.W., Boylan, L.M., Spallholz, J.E. and Morales, J. Modulation of cellular growth in vitro by growth factor inactivation with selenium covalently attached to an inert cellulose matrix. International Congress of Biochemistry and Molecular Biology, August 24-29, 1997, San Francisco, California.
106. Reid, T. W., Smith-Morrow, J. A., Lamberts, D.W., Nishida, T., Murphy, C. J. and Spallholz, J. E. Substance P Mediates Corneal Wound Healing. Keystone Symposia, January 10-15, 1998, Keystone, Colorado.
107. Steward, K., Johnson, M., McCartney, D.L., Murphy, C.J., Mannis, M.J. and Reid, T.W., Effect Of The Bovine Neutrophil Antibiotic Dodeca-Peptide (Bnp-1) On The Viability Of Human Corneal Endothelial Cells Stored In Optisol. Eye Bank Association of Texas, February 28, 1998, Dallas, Texas.
108. Spallholz, J.E., Shriver, B.J. and Reid, T.W., Dimethyldiselenide generates superoxide in an in vitro chemiluminescence assay in the presence of glutathione. Experimental Biology 98, April 18-22, 1998, San Francisco, California.
109. Zang, A., Penturf, M., O'Bannon, S., Griswald, J., Reid, T.W., Spallholz, J. and Boylan, L.M., Topical application of selenocystamine does not promote wound healing in the rat. Experimental Biology 98, April 18-22, 1998, San Francisco, California.
110. M. Shami, J. Wong, C.J. Murphy, R.R. Dubielzig and T.W. Reid The Use Of Antisense DNA Against The Receptors For Platelet Derived Growth Factor, Fibroblast Growth Factor, And Phosphoinositol-3-Kinase In Vitro And To Block PVR In A Rabbit Model Using Human Pigment Epithelial Cells. ARVO, May 10-15, 1998, Ft. Lauderdale, Florida.
111. T.W. Reid, K. Steward, M. Johnson, D.L. McCartney, M.J. Mannis and C.J. Murphy Studies on the effect of the bovine neutrophil antibiotic dodeca-peptide (bnp-1) on the viability of human corneal endothelial cells stored in Optisol. ARVO, May 10-15, 1998, Ft. Lauderdale, Florida.
112. Nicholas Dushku, Daniel M. Albert and Ted W. Reid The Use Of PCR To Test For Human Papillomavirus DNA In P53 Expressing Limbal Stem Cells Of Pinguecula, Pterygia And Limbal Tumors. ARVO, May 10-15, 1998, Ft. Lauderdale, Florida.
113. Marfurt, C.J., Murphy, C.J., Jones, M.A., Reid, T.W. and McDermott, A., Peptidergic innervation of the normal dog cornea and of dog corneas with spontaneous chronic epithelial erosions. ARVO, May 10-15, 1998, Ft. Lauderdale, Florida.
114. Reid, T.W., Spallholz, J.E. and Shriver B. The Use of Selenium Covalently attached to a Cellulose Sponge to Modulate Cellular Growth. Surfaces in Biomaterials ’98, September 2-5, 1998, Tucson, Arizona.
115. Morrow, K.J., Spallholz, J.E., and Reid, T.W., Selenium Conjugates of an Immunoglobulin and a Steroid for use as Prostate Cancer Therapeutics. IBC Symposium on Prostate Cancer: Advances in Diagnostics and Therapeutic Development, November 19-20, 1998, Amelia Island, Florida. Ted W. Reid, Ph.D. 24 Rev 11-27-12
116. Reid, T.W. and P. Tran, Substance P is synergistic with insulin and IGF-1 in the stimulation of corneal epithelial cell migration. American Society for Cell Biology, December 12-16, 1998, San Francisco, California.
117. Reid, T.W., Spallholz, J.E., Xiang, L. and Morales, J., Selenium Covalently Bound To The Surface Of A Cellulose Sponge Used To Modulate Wound Healing After Glaucoma Filtration Surgery, Society for Biomaterials, April 28-May 2, 1999, Providence, Rhode Island.
118. Dushku, N., and Reid, T.W., Abnormal Hras Suppression and Activation in the Altered Limbal Stem Cells (Pterygium Cells) of Pterygia, ARVO, May 9-14, 1999, Ft. Lauderdale, Florida.
119. Reid, T.W., Tran, P. Nishida, T. and Murphy C. J., The Stimulation of Rabbit Corneal Epithelial Cell Migration in Culture by Substance P, is Synergistic with Insulin and IGF-1, ARVO, May 9- 14, 1999, Ft. Lauderdale, Florida.
120. Murphy C. J., Campbell and Reid, T.W., Treatment of Chronic Non-Septic Corneal Epithelial Defects in Dogs Using Topical Substance P and IGF-1, ARVO, May 9-14, 1999, Ft. Lauderdale, Florida.
121. Bentley, E., Abrams, G.A., Covitz, D., Cook, C.S., Reid, T.W., and Murphy C. J., Morphology of Chronic Non-Septic Corneal Epithelial Defects in Dogs, ARVO, May 9-14, 1999, Ft. Lauderdale, Florida.
122. Reid, T.W. and Spallholz J., Selenium Covalently Attached to Biomaterials Blocks Biofilm Formation, 11th Symposium on the Material Science and Chemistry of Contact Lenses, November 10-12, 1999, New Orleans, LA.
123. Dushku, N., M.K. John, G.S. Schultz, and T.W. Reid, Pterygia Pathogenesis: Corneal invasion by matrix metalloproteinase (MMP) expressing altered limbal basal Stem cells and activation of fibroblasts. , ARVO, April 30-May 5, 2000, Ft. Lauderdale, Florida.
124. Campbell, S.F., Reid, T.W., and Murphy, C.J., The effects of growth factors, neuropeptides and neurotransmitters on NGF content in SV-40 transformed human corneal epithelial cells. ARVO, April 30-May 5, 2000, Ft. Lauderdale, Florida.
125. Murphy, C.J., Campbell, S.F. and Reid, T.W. Modulation of SV-40 transformed human corneal epithelial cell proliferation, migration, and adhesion by nerve growth factor. ARVO, April 30- May 5, 2000, Ft. Lauderdale, Florida.
126. Reid, T.W., N. Dushku, M.K. John, and G.S. Schultz, The role of matrix metalloproteinases (MMP) in corneal invasion by altered limbal basal stem cells and the activation of fibroblasts of pterygia. American Society for Cell Biology, December 9-13, 2000, San Francisco, California.
127. Murphy, C. J., Marfurt, C., and Reid, T.W., SP and Chronic non-healing Epithelial Defects in Dogs, ICER, October 15-20, 2000 Santa Fe, NM.
128. Reid, T.W. Selenium covalently bound to surfaces of different materials can modulate cellular attachment by the delivery of superoxide radicals to the surface of the material. Surfaces in Biomaterials, August 30-September 2, 2000 Scottsdale, AZ. Ted W. Reid, Ph.D. 25 Rev 11-27-12
129. Morrow, K.J., Spallholz, J.E. and Reid T.W, Selenium Conjugates of an Immunoglobulin and a Steroid for Use as Prostate Cancer Therapeutics, 7th International Symposium on Selenium in Biology and Medicine, October 1-5, 2000 Venice Italy
130. Spallholz, J.E., Shriver, B., Boylan, L.M. and Reid T.W, Selenium: preventing and treating cancer in the new millennium. 7th International Symposium on Selenium in Biology and Medicine, October 1-5, 2000 Venice Italy
131. Reid, T.W., Dushku, N., John, M.K. and Schultz, G.S. The role of matrix metalloproteinase (MMP) in corneal invasion by altered limbal basal stem cells and the activation of fibroblasts of pterygia. American Society for Cell Biology, December 9-13, 2000, San Francisco, California.
132. Reid, T.W. and Spallholz, J.E. The covalent attachment of selenium to the surface of different ocular materials can modulate cellular attachment by the delivery of superoxide radicals to the surface of the material. Society for Biomaterials, April 24-29, 2001 Saint Paul, MN.
133. Reid, T.W., Schneider, B. G. and Dushku, N. Accumulation of p53 protein in isolated pterygial epithelium is not accompanied by TP53 gene mutation. ARVO, April 30-May 5, 2001, Ft. Lauderdale, Florida.
134. Reid, T.W. and Spallholz, J.E. Organo-selenium attached to a matrix delivers superoxide radicals. The 6th US-Japan Symposium on Drug Delivery Systems December 16-21, 2001 Maui, HI
135. Mathews, S.M., Spallholz, J.E. Dubielzig, R.R., Grimson, M.J. and Reid, T.W. The Efficacy of an Organo-Selenium Coating on Silicone Hydrogel Contact Lenses. ARVO. May 5-10, 2002, Ft. Lauderdale, Florida.
136. Reid, T.W., Tran P., and Fralick, J.A. Counter Terrorism Measures to Combat Yersinia pestis with Selenium. 2002 Joint Service Scientific Conference on Chemical & Biological Defense Research, November 19-21, 2002, Hunt Valley MD.
137. Reid, T.W., Spallholz, J.E. Dubielzig, R.R., Grimson, M.J. and Mathews, S.M. Modulation of Bacterial Attachment to the Surface of Silicone Contact Lenses as a Result of the Formation of Superoxide Radicals on the Surface of the Polymer by Covalently Bound Organo-Selenium. American Chemical Society 224th National Meeting, August 18-22, 2002, Boston, MA.
138. Kerr, T., Gray, T. and Reid, T.W. Interaction between Substance P, EGF, FGF and IGF-1 on the Release of Internal Calcium in Cells in Culture, American Society for Cell Biology, December 14-18, 2002, San Francisco, California.
139. Reid, T.W., Tran P., Spallholz J., and Fralick, J., Counter Terrorism Measures to Combat Yersinia pestis with Selenium. Annual Meeting of the Consortium of Biological Defense Researchers, April 28-30, 2003, Lubbock, TX.
140. Reid, T.W., John, M., Dushku, N., Pearson, K.E., Stephan, D.A., Schultz, G. and Carper, D., Microarray Gene Expression in Pterygia, ARVO, May 4-9, 2003, Ft. Lauderdale, Florida. Invest. Ophthalmol Vis Sci. 2003;4:E1327 www.iovs.org Ted W. Reid, Ph.D. 26 Rev 11-27-12 141. Reid, T.W., Tran P., Spallholz J., and Fralick, J. The use of a selenium-peptide to specifically inactivate Yersinia pestis. 2003 Joint Service Scientific Conference on Chemical & Biological Defense Research, November 17-20, 2003, Hunt Valley MD.
142. Kerr, T., Gray, T., McAnulty, J., Murphy, C. and Reid, T. Use of the Defensin Peptide BNP-1 and the Neuropeptide Substance P to Protect Cells under Stress, American Society for Cell Biology, December 13-17, 2003, San Francisco, California.
143. Murphy, C.J., Foley, J.D., Waller, K.R., Reid, T.W. and McAnulty, J.F. Trophic Factors Modulate Signal Transduction Pathways in Cold-Stored Kidney Cells. American Society for Cell Biology, December 13-17, 2003, San Francisco, California.
144. Spallholz, J., Gray, T, and Reid, T.w. Se-methylselenocysteine (SeMC) and Selenomethionine Likely Induce Apoptosis Enzymatically Arresting Human Cancer Cell Growth In Vitro. NIH meeting on Selenium MD December 17-19, 2003, Bethesda, MD.
145. C.A. Cox, M.John-Aryankalayil, C.Jaworski, P.Russell, T.Gray, K.Freedman, N.Dushku, T.W.Reid, D.Carper. Doxycycline inhibits the migration of cultured human pterygial epithelial cells NIH Research Festival, June 18, 2004
146. M. John-Aryankalayil, N. Dushku, C.J. Jaworski, C.A.Cox, G. Schultz, K.E. Pearson, D.A. Stephan, T.W. Reid and D.A. Carper. cDNA Microarray Analysis of Pterygia, International Congress Of Eye Research, Sydney, Australia, June 24, 2004
147. T.W. Reid, T.J. Gray, C.J. Murphy, A study of the Substance P Stimulation of Calcium Release in Human Corneal Epithelial Cells in vitro ARVO, April 25 - 29, 2004, Ft. Lauderdale, Florida. Invest. Ophthalmol Vis Sci. 2004;45: E-Abstract 2939 www.iovs.org
148. C.A. Cox, M. John–Aryankalayil, C. Jaworski, P. Russell, T. Gray, K. Freedman, N. Dushku, T.W. Reid, and D. Carper The Effect of Doxycycline on the Migration of Pterygial Epithelial Cells grown in Culture Invest. Ophthalmol. Vis. Sci. 2004 45: E-Abstract 2939 www.iovs.org
149. T. W. Reid, S. M. Mathews, M.J. Grimson, , J.E. Spallholz, J.E, Selenium Coated Contact Lenses: Effect Upon Corneal Epithelial Cells and Bacterial Biofilm Attachment 7th World Biomaterials Congress May 17-21, 2004, Sydney, Australia
150. E. Bentley, C.F. Marfurt, A.M. McDermott, R.T. Carter, T.W. Reid, C.J. Murphy. Characterization of unique alterations in the extracellular matrix and innervation of spontaneous chronic corneal epithelial defects in dogs. 5th World Cornea Congress, Washington, D.C. April 13-15, 2005.
151. C.A. Cox, A. Martinez, T.W. Reid, N. Dushku, C. Jaworski, M. John-Aryankalayil, and D.A. Carper, Doxycycline’s effect on the angiogenic potential of pterygial epithelial cells. ARVOMay 1-5, 2005, Ft. Lauderdale, Florida. Invest. Ophthalmol Vis Sci. 2005;46: E- Abstract 959 www.iovs.org
152. X. Zhou, P.L. Tran, J. Fralick, and T.W. Reid. Design and structure determination of a selenium labeled peptide antimicrobial. Protein Society, San Diego CA, June 18-23, 2005. Ted W. Reid, Ph.D. 27 Rev 11-27-12
153. Reid, T.W. Be Radical: Factor selenium into your product equation. Bio2005, Philadelphia, PA June 19-22, 2005.
154. C.A. Cox, A. Martinez, J. Amaral, R. Salloum, A. Garrick, T.W. Reid,, C. Jaworski, M. John-Aryankalayil, K.A. Freedman, S.P. Becerra, and D.A. Carper, Doxycycline’s effectively inhibits Ocular Angiogenesis.. ARVO April 30 - May 4, 2006, Ft. Lauderdale, Florida. Invest. Ophthalmol Vis Sci. 2006;47: E-Abstract 3758 www.iovs.org
155. C. Jaworski, M. John-Aryankalayil, M.M. Campos, R.N. Fariss, J. Rowsey, T.W. Reid, N. Dushku, C.A. Cox, G. Wistow, and D.A. Carper, EST analysis of human pterygium cDNA library. ARVO April 30 - May 4, 2006, Ft. Lauderdale, Florida. Invest. Ophthalmol Vis Sci. 2006;47: E-Abstract 4985 www.iovs.org
156. B. Winsor and T. Reid, “Treatment of Chronic Ulcers with Topical Substance P and Insulin- like-Growth Factor. “Wound Care – Stuttgart 2005, Stuttgart, Ger. September 15-17, 2006.
157. T. Reid and Julian Spallholz, “The Use of Selenium to Arm Antibodies.” 5Th Antibody World Summit, San Jose CA, June 12, 2006.
158. Reid, T. W., Mathews, S.M., Grimson, M.J., Dubielzig, R., Spallholz, J.E. “\Selenium Coated Contact Lenses: Effect Upon Corneal Epithelial Cells and Bacterial Biofilm Attachment. Selenium 2006, Madison, Wisconsin July 25, 2006
159. Reid, T.W. and Julian Spallholz, “ Organo-Selenium covalently bound to the surface of different materials can modulate cellular attachment by the delivery of superoxide radicals to the surface of the material. Selenium 2006, Madison, Wisconsin July 26, 2006
160. Reid, T.W., Murphy, C.J., McAnulty, J.F., and Wolcott, R. The use of substance P in wound healing and tissue preservation in humans, dogs and rabbits. Neuropeptide conference, Santorini, Greece, April 19-22, 2007.
161. Reid, T.W., Murphy, C.J., McAnulty, J.F., and Wolcott, R. The role of substance P in wound healing and tissue preservation in humans, dogs and rabbits. Gordon Research Conference, Colby-Sawyer College, June 17-22, 2007.
162. Tran, P., Fralick, J., Spallholz, J. and Reid, T.W. Use of selenium containing peptides and phage to selectively kill Yersinia pestis. Texas Tech University Health Sciences Center Research Day, Lubbock, TX. March 13, 2008.
163. Tran, H., Gray, T. and Reid, T.W. The ability of substance P to stimulate Calcium release in a drug delivery system. Howard Hughes Medical Research Institute Research Days, Lubbock, TX, April 3-4, 2008.
164. Reid, T.W., Tran, P., Mosley, T., Gray, T., Hammond, A., Cortez, J., Shashtri, M., Spallholz, J. and Hamood, A. Selenium covalently bound to a wound bandage inhibits the attachment of bacteria. 18th Annual Meeting of the Wound Healing Society SAWC/WHS Joint Meeting, San Diego CA, April 24-27, 2008. Ted W. Reid, Ph.D. 28 Rev 11-27-12 165. Pot, S.A., Chandler, H.L., Colitz, C.M., Bentley, E., Dubielzig, R.R., Mosley, T.S., Reid, T.W. and Murphy, C.J., Selenium functionalized intraocular lenses inhibit posterior capsule opacification (PCO) in an ex vivo canine lens capsular bag assay. American Congress of Veterinary Ophthalmologists, Boston, MA May, 9, 2008.
166. Pot, S.A., Chandler, H.L., Colitz, C.M., Bentley, E., Dubielzig, R.R., Mosley, T.S., Reid, T.W. and Murphy, C.J., Inhibition of posterior capsule opacification (PCO) by selenium functionalization of intraocular lenses in an ex vivo canine lens capsular bag assay. European Congress of Veterinary Ophthalmologists, Versailles, France June, 23, 2008. 167. Low, T., Jackson, A., Morse, A., Mosley, T., Reid, T.W., Selenium Coating of Water Distribution Tubing to Inhibit Biofilm, presented at International Conference On Environmental Systems, June 2008, San Francisco, CA, USA June 2008
168. Tran, P.L., Hammond, A.A., Mosley, Janette Cortez, J., Gray, T., Colmer-Hamood, J.A., Shashtri, M., Spallholz, J.E., Hamood, A.N. and Reid, T.W. Bandages Coated With Organo-Selenium Inhibit Bacterial Attachment. Society for Biomaterials Meeting, April, 22-25, 2009.
169. Reid, T. W. and Wolcott, R., Wound healing in humans and rabbits using substance P. Wound Healing Society Meeting, Dallas, TX April 26-29, 2009.
170. Reid, T., Tran, P., Cortez, J., Mosley, T., Shashtri, M., Spallholz, J., Pot, S. and Hamood., A. Medical Devices Coated with Organo-Selenium Inhibit Bacterial and Cellular Attachment. International Medical Device Conference, San Jose, CA, September 14-15, 2009.
171. Yang, W., Bradley, J., McCartney, D., and Reid, T. Growth Factors in Aqueous Humor of Diabetic and Non-Diabetic Eyes. Amer. Acad of Ophthalmology Meeting, San Francisco, CA, October, 24-27, 2009.
172. Cordero, J., Marchbanks, J., Tran, P., Mosley, T., Cortez, J., Timmons, R., Hamood, A., and Reid, T. An Organo-Selenium Coating of Tympanostomy Tubes Inhibits the Development of Bacterial Biofilms. Amer Acad of Otolaryngology-Head and Neck Surgery Meeting, San Diego, CA October 4-7, 2009.
173, Phat Tran, Thomas Mosley, Mayank Shashtri, Janette Cortez, Abdul Hamood, Ted W. Reid, Comparison of Bandages Coated With Organo-Selenium or Silver for Their Ability to Inhibit Bacterial Attachment, Society for Biomaterials, College Station, TX., February 21, 2010
174. Kakarala, Kokila, Cassie Versteegh Kruczek, Thomas Mosley, Janet Dertien, Abdul Hamood, and Ted Reid, Selenium cream inhibits biofilm development by bacterial isolates from burn wounds. TTUHSC Student Research Symposium, February 24, 2010
175. Campbell, Thomas, Thomas Mosley, Janet Dertien, Ted Reid, John Griswold, Alexander Horswill, and Abdul Hamood, Selenium inhibits S. aureus biofilms on both surfaces of hemodialyis catheters. TTUHSC Student Research Symposium, February 24, 2010
176. Reid, T., What a study of Pterygia teaches us about the Cornea, International Symposium 2010, Yamaguchi, Japan, March 19-23, 2010. Ted W. Reid, Ph.D. 29 Rev 11-27-12
177. Mercer, R., and Reid, T.W. The Effect of Selenium Compounds on the Prevention of S. aureus Biofilm Formation on Contacts Lenses, Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 3, 2010
178. Dhiman Bhattacharyya, Rajendrasing R. Deshmukh, Ted Reid, Thomas Mosley and Richard B. Timmons. Single-Step Pulsed Plasma Polymerization of Diphenyldiselenide and its antimicrobial activity. American Chemical Society Meeting, Boston, MA. August 25, 2010.
179. Reid, T., Tran, P., Mosley, T Tran ,K Jarvis,C. Patel S., Shashtri, M., and Hamood., A. Biopolymers Containing Selenium: Their Synthesis and Use. International Medical Device Conference, San Jose, CA, September 28-29, 2010.
180. Reid, T., Tran, P., Mosley, T., Tran, K., Jarvis., Thomas, J., Hanes, R., Webster, D., Hamood, A., Use of Biopolymers Containing Selenium for Biofilm Prevention During Wound Healing. Wound Healing Society Meeting, Grapevine, TX., April, 16, 2011.
181. Mitchell, K., Arnett, A.I., Auten, J-C., Hanes, R., Jarvis, C.C., Thomas, J., Hamood, A., Dominguez, L., Reid, T.W., The Use Of A Covalent Selenium Coating To Inhibit Biofilm Formation On A Silicone Scleral Buckle. Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 5, 2011.
182. Scott AM, Haley C, Reid TW, Mosley T, and Hamood A, Selenocystamine inhibits the growth of opportunistic pathogen P. aeruginosa, and prevents biofilm formation. Texas, American Association for Microbiology, Dallas November 12, 2011.
183. Tran P, Reid TW, Lowry N, Tobin E, Aslani A, Colmer-Hamood J, Mosley T, Dertien J, and Hamood A, Selenium inhibits S. aureus biofilms on hemodialysis catheters in vivo. Texas, American Association for Microbiology, Dallas November 12, 2011.
184. Scott AM, Haley C, Reid TW, Mosley T, and Hamood A, Selenocystamine inhibits the growth of opportunistic pathogen P. aeruginosa, and prevents biofilm formation NCUR conference Ogdon Utah March 29, 2012.
185. Wang, JC, Tran, P, Corder, J, Marchbanks, J, Reid, TW, Hamood, A. Selenium coated Tympanostomy Tubes inhibit Staphylococcus aureus and Haemophilus influenzae Biofilms: in vitro and in vivo analysis. TTUHSC, March 2012
186. Enos, T, Tran, P, Reid, TW, Jarvis, C, Mosley, T, Hamood, A, Selenium coated polyester bandage inhibits the growth of Staphylococcus aureus. TTUHSC, March 2012.
187. Tran, P., Hamood, A., Mosley, T., Jarvis, C., Thomas, J. Lackey, B., and Reid, T.W. Organo- Selenium Coated Contact Lenses: Effect Upon Bacterial Biofilm Attachment. Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 3, 2012.
188. Mitchell, K., Tran, P., Arnett, A.I., Mosley, T., Hanes, R., Jarvis, C., Hamood, A., Dominguez, L., and Reid, T.W. Organo-selenium coatings inhibit multiple species of Ted W. Reid, Ph.D. 30 Rev 11-27-12 biofilm formation on ophthalmic device material. Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 3, 2012.
189. Reid, T.W., Tran, P., Mosley, T., Jarvis, C., Thomas, J., Tran, K., Hanes, R., Hamood, A. Antimicrobial properties of selenium covalently incorporated into the polymer of contact lens case material. Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 3, 2012.
190. Jansen, M.E., Good, D., Sidhu, S., Kaufman, J., Mosley, T., Reid, TW. Testing of a Selenium (Se) Coated Biomaterial for Use in Glaucoma Surgery. Association for Research in Vision and Ophthalmology Meeting, Fort Lauderdale, FL, May 3, 2012.
191. Reid, T.W., Tran, P., Mosley, T., Jarvis, C., Nguyen, Hieu, Hanes, R, Hamood, A. A Selenium Polyurethane Foam Bandage Material for Biofilm Prevention During Wound Healing. Wound Healing Society Meeting, Atlanta GA., April 19, 2012.
192. Enos, T, Tran, P, Reid, TW, Jarvis, C, Colmer-Hamood, J, Hamood, A, Selenium coated polyester bandage inhibits the formation of bacterial biofilms. TTUHSC, March 2013.
193. Reid, TW, Tran, P, Mosley, T, Jarvis, C, Webster, D, Hanes, R, Hamood, A. Selenium covalently incorporated into the polymer of contact lens case material inhibits bacterial biofilm formation. Association for Research in Vision and Ophthalmology Meeting, Seattle, WA, May 5, 2013
194. Tran, P, Hamood, A, Webster, D, Jarvis, C, Hanes, R, Reid, TW. Selenium Contact Lens Hydrogel Polymer: Inhibition of Bacterial Biofilm Formation. Association for Research in Vision and Ophthalmology Meeting, Seattle, WA, May 5, 2013
MEETINGS/CONFERENCES/COURSES/PRESENTATIONS:
10/9-12/79 CONFERENCE ON BIOCHEMISTRY OF THE EYE Oakland University Rochester, Michigan Talk by Ted W. Reid: The Characteristics of a Growth Factor Isolated from Human Retinoblastoma Cells in Tissue Culture.
10/22-23/79 MEETING ON OCULAR TISSUE CULTURE National Institutes of Health Bethesda, Maryland Talk by Ted W. Reid: The Nature of a Newly Discovered Growth Factor from Retinoblastoma Cells.
11/4-8/79 ANNUAL MEETING OF THE SOCIETY FOR CELL BIOLOGY Toronto, Canada Ted W. Reid, Ph.D. 31 Rev 11-27-12 Presentation by Sham L. Pahuja, Brian T. Mullins, and Ted W. Reid: Comparison of Molecular and Kinetic Characteristics of Glutamine Synthetase from Brain Cells and Retinal Cells.
Presentation by Norman A. Rubin, Andrew Borthwick, J. Albert, D.S. Gregerson, and Ted W. Reid: Identification and Characterization of a Mitogenic Factor Secreted by an Established Cell Line of Human Retinoblastoma Maintained in Serum-Free Media.
1/24-25/80 SPECIAL SEMINAR Ophthalmology Research Center The Medical College of Wisconsin Milwaukee, Wisconsin Talk by Ted W. Reid: Growth Factors and Their Effects on Ocular Cells.
5/8/80 SEMINAR Imperial Cancer Research Fund Laboratories London, England Talk by Ted W. Reid: Ocular Growth Factor Derived from Retinoblastoma Cells In Culture.
6/5/80 SEMINAR Ophthalmology Institute of London Talk by Ted W. Reid: Ocular Growth Factor Derived from Retinoblastoma Cells in Culture.
10/2/80 FOURTH INTERNATIONAL CONGRESS FOR EYE RESEARCH Talk by Ted W. Reid: Effect of Retinoblastoma Derived Growth Factors on the Growth of Lens Cells in Culture
11/10/80 SEMINAR National Eye Institute/National Institutes of Health Bethesda, Maryland Talk by Ted W. Reid: Control of Cell Growth by Potassium
11/21/80 SEMINAR Brooklyn College Brooklyn, New York Talk by Ted W. Reid: Control of Cell Growth by Potassium
9/21-24/81 INSERM MEETING Paris, France Talk by Ted W. Reid: Effect of Retinoblastoma Derived Growth Factors on Cells in Culture
6/7-9/82 FOURTEENTH MILES INTERNATIONAL SYMPOSIUM Baltimore, Maryland Talk by Ted W. Reid: Cell Fusion Ted W. Reid, Ph.D. 32 Rev 11-27-12 12/15/83 SEMINAR Revlon Corp. Research Center Springfield, Virginia Talk by Ted W. Reid: Mechanism of Action of Retinoblastoma Growth Factor
1/24/84 SEMINAR Cornell University Medical School New York, New York Talk by Ted W. Reid: Genetic Factors in Retinoblastoma Cells
4/19/84 SEMINAR University of California, Davis Medical Center Sacramento, California Talk by Ted W. Reid: Retinoblastoma, Possible Causes
5/15/84 SEMINAR Yale University Medical School Human Genetics department New Haven, Connecticut Talk by Ted W. Reid: Mechanism of Insulin Stimulation of Cell Growth
7/10/84 SEMINAR National Institutes of Health, National Eye Institute Bethesda, Maryland Talk by Ted W. Reid: Retinoblastoma Derived Growth Factor Stimulation of Tyrosine Phosphorylation
8/27/84 SEMINAR University of Illinois, Department of Dairy Science Urbana, Illinois Talk by Ted W. Reid: Growth Factors in the Eye
8/30/84 University of Colorado Department of Chemistry Boulder, Colorado Talk by Ted W. Reid: Mechanism of Ocular Growth Factors
2/4/85 University of California, Davis Human Anatomy Department Davis, California Talk by Ted W. Reid: Growth Factor Control of Cellular Proliferation
4/16/85 University of California, Davis Neurobiology Study Group Davis, California Talk by Ted W. Reid: Retinoblastoma: Growth Control
5/22/85 Imperial Cancer Research Fund London, England Talk by Ted W. Reid: Kinetics of Insulin Stimulation of Cell Growth Ted W. Reid, Ph.D. 33 Rev 11-27-12
5/23/85 University of London Institute of Ophthalmology London, England Talk by Ted W. Reid: Oncogenes and Retinoblastoma
11/26/85 Allergan Pharmaceutical Company Irvine, California Talk by Ted W. Reid: Inhibition of Unwanted Cell Multiplication in the Eye
11/27/85 Occidental College Department of Chemistry Los Angeles, California Talk by Ted W. Reid: The Nature of Cell Growth Control in the Eye
1/22/86 Louisiana State University Department of Microbiology and Immunology New Orleans, Louisiana Talk by Ted W. Reid: Growth Factors and Control of Cellular Growth
7/17-18/86 Allergan Pharmaceutical Company Irvine, California Talks by Ted W. Reid: Growth Factors in the Eye Wound Healing in the Eye
10/87 Yale University New Haven, Connecticut Talk by Ted W. Reid Growth Factors in the Eye
9/89 Western Eye Research Meeting Timberline, Oregon Talk by Ted W. Reid: The Antimicrobial Peptides - Defensins - Stimulate Ocular Cell Growth
10/89 Chiron Los Angeles, California Talk by Ted W. Reid: New Wound Healing Agents for the Eye
10/89 Allergan Los Angeles, California Talk by Ted W. Reid: RbDGF as a Wound Healing Agent
12/89 Texas Tech University Lubbock, Texas Talk by Ted W. Reid: Growth Factors for Wound Healing in the Eye
12/89 Alcon Ted W. Reid, Ph.D. 34 Rev 11-27-12 Fort Worth, Texas Talk by Ted W. Reid: New Wound Healing Agents for the Eye
1/90 UCLA Molecular Biology Symposium Keystone, Colorado Talk by Ted W. Reid: Modulation of the Glucocorticoid Receptor by Growth Factor Receptors
2/90 AMGEN Thousand Oaks, California Talk by Ted W. Reid: Converting Growth Factors to Growth Inhibitors
2/90 Triton Inc. Alameda, California Talk by Ted W. Reid: The Ligand for the Erb-B2 Receptor
3/90 University of Arizona Tucson, Arizona Talk by Ted W. Reid: Basic Research in Ophthalmology
6/90 Texas Tech University Lubbock, Texas Talk by Ted W. Reid: Growth Factors and Wound Healing in the Eye
6/91 Texas Tech University Lubbock, Texas Talk by Ted W. Reid: Growth Factors in the Eye
8/90 Contemporary External Disease Incline Village, NV Talk by Ted W. Reid: Growth Factors and Wound Healing
6/91 Alcon Pharmaceutical Inc., Fort Worth, TX Talk by Ted W. Reid: "The use of growth factors to treat wound healing problems in the eye"
10/91 Allergan Inc., Irvine CA Talk by Ted W. Reid: Use of SP to treat ocular wounds".
9/91 Biochemistry and Molecular Biology Dept Texas Tech University Lubbock, Texas Talk by Ted W. Reid: "Designing growth factor inhibitors"
9-10-92 Area Science Teachers Workshop Texas Tech University Lubbock TX Talk by Ted W. Reid: "How does the eye work?"
2-16-93 Biochemistry and Molecular Biology Dept Ted W. Reid, Ph.D. 35 Rev 11-27-12 Texas Tech University Lubbock, Texas Talk by Ted W. Reid: SP as a Growth Factor
12-16-92 Khepri Inc. Palo Alto, CA Talk by Ted W. Reid: "Prevention of secondary cataract with enkephalinase"
1-19-93 Khepri Inc. Palo Alto, CA Talk by Ted W. Reid: "Enkephalinase binding to IOLs"
4-14-93 Physiology Dept Texas Tech University Lubbock, Texas Talk by Ted W. Reid: Analogs of SP as Growth Factors
4-21-93 Science Spectrum Talk by Ted W. Reid: "How does the eye work"
3-27-93 Texas Society to Prevent Blindness Talk by Ted W. Reid: "Prevention of secondary cataract"
7-2-93 Ophthalmology Dept. Yale University School of Medicine New Haven CT. Talk by Ted W. Reid: "Rational drug design"
8-23-93 Texas Biotechnology Corp. Houston, TX Talk by Ted W. Reid: "Rational drug design of neuropeptides involved in wound healing and cell growth."
1-14-94 Western Eye Research Conference UCLA conference center, Lake Arrow Head, California Talk by Ted W. Reid: "Specificity in Target Cell Responses to Growth Factors"
2-23-95 Texas College of Osteopathic Medicine Fort Worth, TX Talk by Ted W. Reid: " The mechanism of the interaction of Substance P with its receptor and its role in disease mechanisms"
4-5-95 to University of Wisconsin-Madison, Medical School 4-7-95 Madison, Wisc. Visiting Professorship for Ted W. Reid: " Substance P: Possible Roles in Ocular Wound Healing and Future Drug Design"; "Pterygia: Cause and Potential Cure"; "Filtering Procedures: A New Technique Involving Selenium" Ted W. Reid, Ph.D. 36 Rev 11-27-12
5-17-95 ARVO Special Symposium on Substance P Ft. Lauderdale, FL Talk by Ted Reid on the SP receptor subtypes in the eye.
7-26-95 Television presentation for the California Kaiser Hospital Physicians. Oakland, CA Pterygia and Corneal Growths - 1 Hour talk with Dr. Nic Dushku, Moderated by Dr. H. Minkoff
3-28-96 Questers Discussion Group Lubbock, TX Talk by Ted W. Reid: "The ability of sunlight to cause a Pterygium and the role of the p53 mutation".
4-20-96 University of Miami Bascon Palmer Eye Institute Miami, FL Talk by Ted W. Reid: The role of basement membrane in ocular epithelial cell p53 expression and limbal stem cell migration.
7-1-96 Alcon Pharmaceutical Fort Worth, TX Talk by Ted W. Reid: "The ability of selenium coating to block secondary cataract formation in the eye".
11-30-96 University of Illionis, Chicago Department of Ophthalmology Chicago, IL Talk by Ted W. Reid: “Substance P: Designing a drug for corneal wound healing based upon it mechanism of action”.
2-3-97 Biotechnology Institute Texas Tech University Lubbock, TX Talk by Ted W. Reid: " The design of a drug to heal non-healing ulcers.
2-26-97 Department of Biological Sciences Texas Tech University Lubbock, TX Talk by Ted W. Reid: "Substance P: Mechanisms of Control of Epithelial Cell Growth"
9-22-97 Research to Prevent Blindness Science Writers Conference Los Angeles, California Talk by Ted W. Reid: "Shining new light on pterygia"
10-28-97 Protein Design Laboratories, Inc. Mountain View, California Ted W. Reid, Ph.D. 37 Rev 11-27-12 Talk by Ted W. Reid: "The Use of Selenium Covalently Attached to Antibodies to Improve Their Ability to Selectively Kill Cells"
11-1-97 Talk to Agricultural Chemistry Class Texas Tech University Lubbock, TX Talk by Ted W. Reid: "The design of New Substance P Molecules to Heal Epithelial Wounds"
11-20-97 Honors Department Texas Tech University Lubbock, TX Talk by Ted W. Reid: "The use of Substance P to Heal Epithelial Wounds"
1-14-98 The Southwest Cancer Center University Medical Center Lubbock, TX Talk by Ted W. Reid: "The use of phage display libraries to design drugs"
1-31-98 Talk to Lubbock Round Table Forum Lubbock Club Lubbock, TX Talk by Ted W. Reid: "New Research Ventures"
5-30-98 Update for the Comprehensive Ophthalmologist Holiday Inn Civic Center Lubbock, TX Talk by Ted W. Reid: "Corneal Albedo"
12.15.98 Talk to Regional American Chemical Society Section Amarillo Steak House Amarillo, TX Talk by Ted W. Reid: “Designing a drug for corneal wound healing”
4-19-99 Talk to Taps Pharmaceutical Deerfield IL Talk by Ted W. Reid: “On the ability of analogs of substance P to yield information as to the nature of its receptor”
1-26-00 Talk to Ciba Vision Duluth, Georgia Talk by Ted W. Reid, “The surface modification of Contact Lenses”.
8-30-00 Talk to Surfaces in Biomaterials 2000 Scottsdale AZ Ted W. Reid, Ph.D. 38 Rev 11-27-12 Talk by Ted W. Reid, “Selenium covalently bound to surfaces of different materials can modulate cellular attachment by the delivery of superoxide radicals to the surface of the material.”
11-13-01 Talk to the Microbiology Department of LSU New Orleans, LA Talk by Ted W. Reid, "Substance P: Nerves and Wound Healing"
4-26-02 Gifford/Truhlsen Lecturer at the University of Nebraska Ophth. Dept, Omaha, NB Talk by Ted W. Reid, “Development of a Treatment for Non-Healing Corneal Ulcers – Substance P”
4-26-02 Gifford/Truhlsen Lecturer at the University of Nebraska Ophth. Dept, Omaha, NB Talk by Ted W. Reid, “Development of a Coating for Glaucoma Valves to Block Fibrosis”
7-28-02 Talk to the Microbiology Department, Louisiana State University Medical Center, New Orleans, LA Talk by Ted. W. Reid: “Healing of corneal ulcers by a neuropeptide”
8-21-02 Talk at the American Chemical Society 224th National Meeting Boston, MA Talk by Ted W. Reid, “Modulation of Bacterial Attachment to the Surface of Silicone Contact Lenses as a Result of the Formation of Superoxide Radicals on the Surface of the Polymer by Covalently Bound Organo-Selenium.”
10-17-02 Talk to Regional American Chemical Society Section Amarillo Steak House Amarillo, TX Talk by Ted W. Reid: "The use of organo-selenium to modulate bacterial and mammalian cell growth on a medical device."
11-18-02 Talk at National Eye Institute National Institutes of Health Bethesda, MD Talk by Ted W. Reid: “Pterygia, it cause and the nature of its pathogenesis”
11-27-02 Talk at the Joint Service Scientific Conference on Chemical And Biological Defense Research Hunt Valley Maryland Ted W. Reid, Ph.D. 39 Rev 11-27-12 Talk by Ted W. Reid: “Counter Terrorism Measures to Combat Yersinia Pestis with Selenium Pharmaceuticals”
4-15-03 Talk to the South Plains Optometric Society Lubbock, Texas Talk by Ted W. Reid: “Biofilms and Contact lenses: research on Selenium”
4-30-03 Talk to Annual Meeting of the Consortium of Biological Defense Researchers Lubbock, Texas Talk by Ted W. Reid: “Counter Terrorism Measures to Combat Yersinia pestis with Selenium Pharmaceuticals”
10-25-04 Talk to the Pharmacology Department, Louisiana State University Medical Center, New Orleans, LA Talk by Ted. W. Reid: “Design of new antibiotics for specific bacterial killing”
4-13-05 Talk to Lubbock Homebuilders association Talk by Ted W. Reid: “Designing new drugs”
5-12-05 Talk to Lubbock Regional Bioscience Initiative Talk by Ted W. Reid: Problems of research development”
6-10-05 Lecture for the Gifford-Truhlsen Day at the University of Nebraska Medical Center, Omaha, Nebraska. Talk by Ted W. Reid: Design of a New Type of Antibiotic for Drug Resistant Bacteria
8-26-05 Lecture to the Southwest Cancer Treatment and Research Center Conference Talk by Ted Reid: "The use of selenium labeled antibodies to kill breast cancer cells"
6-12-06 Symposium Talk to the Antibody World Summit San Francisco, CA Talk by Ted Reid: “The use of selenium to arm antibodies”
9-28-06 Lecture to “Biosiris” Gembloux, Belgium Talk by Ted Reid: The design of new substance P molecules for wound healing of diabetic wounds.
5-5-07 Talk at the University of Florida – Gainseville Talk by Ted W. Reid: The use of selenium in the treatment of different ocular problems.
4-3-08 Lecture to San Antonio Orthodontists Talk by Ted W. Reid: The use of selenium to inhibit bacterial attachment to orthodonic devices.
1-24-09 Lecture at South West Dental Society Meeting, Dallas, Texas Talk by Ted W. Reid: The prevention of biofilm formation on teeth by selenium coatings. Ted W. Reid, Ph.D. 40 Rev 11-27-12 1-22-10 Lecture at the Clinical Optometry Update and Review, Lubock Texas Talk by Ted w. Reid: Modulation of Baterial attachment to contact lenses
9-27-10 Lecture to DSMPTG, Berkeley California Talk by Ted W. Reid: Selenium containing polymers
9-30-10 Lecture to CooperVision, Pleasanton California Talk by Ted W. Reid: Selenium coated contact lenses
8-31-11 Lecture to Sybron, Orange California Talk by Ted W. Reid: The use of selenium to block plaque on teeth
11-2-11 Lecture at TTUHSC, El Paso to Dept. of BioMedical Sciences Talk by Ted W. Reid: The role of nerves in wound healing
6-22-12 Lecture at Yale University, New Haven Ct., to the Ophthalmology Department Talk by Ted W. Reid: “The Role of Substance P in Neurotrophic Ulcers” Ted W. Reid, Ph.D. 41 Rev 11-27-12
Lectures and Teaching (2009-2010)
Medical Student Teaching- Lectured to medical students on biochemistry of the eye (1-hour) Resident Teaching – Lectured (6 hours); Pingueculae / Pterygia 8-9-09 Undergraduate Teaching – Lectures in Honors Program Integrated Science (34 hours) Science and Society (24 hours) Graduate Student committees: Darryl Low (Engineering, Ph.D.); Phat Tran (Microbiology, Ph.D.) Medical Student Research advisor Rachel Fredrick – Selenium coating for a contact lens Research Advisor – Undergraduate students Aimee Jimenez (Howard Hughes Scholar) – Selenium Bandages Kokila Kakarala (Honors College Thesis) – Antibacterial ointments Ted W. Reid, Ph.D. 42 Rev 11-27-12
Funding History (2009-2011):
2 R44 DK074187-02 Reid (Co-PI) 07/01/2008 – 08/31/2009 NIH/SIBR, phase II ($1,200,000) Selenium coated dialysis catheters for reduced biofilm formation This research is intended to develop a selenium coating for venous catheters and examine the efficacy of the coating to prevent microbial biofilm development in an animal model. Role: Co-PI
1 R41 DE018260-01 Reid (PI) 04/01/2008 – 03/31/2009 NIH/SIBR, phase I Antimicrobial dental devices and waterlines ($120,000) This research was intended to develop a covalently bound selenium coating for use in dental unit water lines. Role: PI
Funded by private industry Reid (PI) 03/01/2007 – 12/31/2010 Auxano Biologics, Inc. ($240,000) Effect of selenium coated bandages on wound healing This research was intended to examine the effect of a selenium coating on cotton bandages in preventing bacterial biofilm development. Role: PI
1 R41 DE018260-01 Reid (PI) 4/01/2010 – 3/31/2012 NIH/SIBR, phase II ($980,000) Antimicrobial dental devices and waterlines This research was intended to develop a covalently bound selenium coating for use in polyurethane dental unit water lines and surgical waterlines. Role: PI
1 R41DC)010963-01 Reid (PI) 5/01/2010 – 4/31/2011 NIH/SBIR phase I ($155,000) Inhibition of Biofilms on Tympanostomy Tubes This research in intented to develop a covalent bound selenium coating for use in implanted tympanostomy tubes. Role: PI
PC100682 Reid (PI) USAMRMC Phase I ($120,000) 1/17/2011 – 1/16/2012 A cell selective selenoconjugate compound for the treatment of human prostate cancer This research is for the development of an organo-selenium compound that will selectively kill prostate epithelial cells in vivo. Role: PI Ted W. Reid, Ph.D. 43 Rev 11-27-12
Patents:
Title: Patent Number Date Method for the preparation of free radical 5,783,454 July 21,1998 pharmaceutical, diagnostics and devices using selenium conjugates. Filed May 17, 1994 Selenium Carrier Conjugates 5,994,151 November 30, 1999 Method for the preparation of free radical 6,077,714 June 20, 2000 pharmaceutical, diagnostics and devices using selenium conjugates Method for the preparation of free radical 6,040,197 March 21, pharmaceutical, diagnostics and devices using 2000 selenium conjugates Method for the preparation of free radical 6,033,917 March 7, pharmaceutical, diagnostics and devices using 2000 selenium conjugates Method for the preparation of free radical 6,043,098 March 28, pharmaceutical, diagnostics and devices using 2000 selenium conjugates Method for the preparation of free radical 6,043,099 March 28, pharmaceutical, diagnostics and devices using 2000 selenium conjugates Selenium conjugates for the preparation of free 0-804-247 May 7, 2003 radical pharmaceuticals European patent in France, Germany, Italy, Spain and the UK. Filed on May 12, 1995 Transplant Media 6,696,238B2 February 24, Held by Trophic Solutions LLC 2004 1509 Wood Lane Madison, WI 53705 Filed on July 27,2001 Method and Compositions using substance P to 5,616,562 April 1, 1997 promote wound healing Filed on April 27, 1990 (abandoned) Finally filed on July 25, 1994 Inventors: C.J. Murphy, T.W. Reid and M.J.Mannis Defensin peptide compositions and method of use 5,242,902 September 7, Filed on September 6, 1989 1993 Assignee: The Regents of the University of California, Oakland, California Transplant Media 01957315.3 July 27, 2001 European Patent Filed on July 27, 2001 Transplant Media 2001/02417331 July 27, 2001 Canadian Patent Filed July 27, 2001 Transplant Media 2001/000079073 July 27, 2001 Australian Patent Filed July 27, 2001 Ted W. Reid, Ph.D. 44 Rev 11-27-12